1

CARDIOLOGY CENSUS D 3609, 2502,2519, 2413, 1410,1CU3, ICU 7

DECEMBER 12, 2017 T 3803,3804, 3608, 2505,2512,1522(PROC), CCU
ANGHAD-RAMOS/
LUGTU/ANICO TONDO/RTAN PALMEA W 3508,3501, ,3504, 1507B,,1511, 1519,1404, J7,R2,ICU1
H 1501C,1502, 1526,CCU2, CCU5

MEDICAL SUITE
ROOM AP NAME/AGE/ SEX NON CARDIAC DIAGNOSIS CARDIAC DIAGNOSIS DIAGNOSTIC RESULTS PRESENT PROBLEM/ PROCEDURE/
# FOLLOW UP/ MEDS
3801A ADC AGUIRRE RODOLFO DMT2 HCVD PROB CAD WBC 6.0 HGB 155 PLT 195 NA 140 K 4.1 CREA 100 UA 408 AWAITING CT CORO ANGIO
624758 65M S/P TIA? ECG NSR 12/11/17CITICOLINE CLOPI ATOR
12/9 EF 52% N LVD and WT with mild HK of the entire IVS from mid to GLICLA AMLO
apex, inferior LVFW from base to apex with DERA N PAP
MRI: NO ACUTE INFARCT /HGE , MRA MILD LEFT PETROUS ICA IRREG,
NARROWING MID BILATERAL PCA LMCA R VERTEBRAL CONTOUR IRREG

3801B ADC AGUIRRE CONCEPCION HCVD 12/11 THYROID FUNCTION TEST - NORMAL COMPLETION CRANIAL STUDY
59F 12/9 EF 64% N LVD AND WT W/ AWMC TELMI ATOR
ECG NSR W/ PAC
NEGATIVE MRI/MRA, SUSPICIOUS VENOUS ANGIOMA R BG
3803 TDY JOSE CASTANEDA 70M CVA INFARCT R HCVD WBC 5.5 HGB 99 PLT 279 NO OBJ TO D/C
624684 DMT2 CREA 127 NA 139 K 4.0 GFR SCAN TODAY
CKD ECG : 1ST D AVB CRBBB LVH
BPH REFERRED TO NEURO
CT SCAN: SMALL ACUTE INFARCT LEFT CORONA RADIATA
MEDS: CILOSTAZOL,
METHYCOBALAMIN, JANUMET
FINASTERIDE SITA+METFORMIN
GLIMEPRIDE FELODIPINE
FENOFIBRATE TELMI FURO
CITICOLINE
3804 TDY CHUA SE GUIOC 88/F CKD SEC TO HTNNS HCVD DCMP 1VCAD SR NYHA 12/11 CREA 276 NA 140 K 5.4 CXR:BPC, PNEUMONIA RLL
624474 FC II 12/10: HGB 109 WBC 6.1 PC 188 CREA 215
S/P CA 2015 12/8 CREA 224 CANDESARTAN FURO
S/P C A12/6 1 V CAD RCA 12/7 crea 236 k 4.1 SIMVAST NADES IMDUR CLOPI
S/P ATTEMPTED PCI RCA ECG: SR, 1DAVB, NSSTWC, LVH CLONI NIFEDIPINE KEROBEST
NEVIBOLOL
B FEM
12/11 PIPTAZO
S/P FEM CATH REMOVAL
BILAT WBC HGB 119 WBC 5.4 PLT 201 SEG 68 LYPHO 18
NA 138 K 4.5 BUN 24.1 CREA 285

PT 12.4 INR 1.10 ACT 82% APTT 32.3

ECHO 11/17: EF 33% DIL LV W/ NWT AND GEN SEVRE HK W/ ONLY THE
BASAL SEGMENT OF THE INFEROLATERAL WALL SHOWING SOME DEGREE
OF CONTRACTILITY FNDINGS C/W DCMP W/ DEC SYS FXN, DI LA, MITRAL
SCLEROSIS W/ MILD MR, AORTIC SCLEROSIS W/ MILD AR, MIL DPULMO
HTN
3807 LTAN ENG AN LAO 82/ M AGE WITH SOME SIGNS OF 12/11 FECALYSIS - NORMAL K NBE
624896 DEHYDRATION ECG ST CIPRO
HGB 136 WBC 11.7 S94 PC 102 METRO
PARACETAMOL
CREA 98 SGPT 20 NA 132 K3.4
KLYTE

3809 TDY JUSTINO CU 83M CAPMR HCVD PROB CAD SR NYHA 12/8 WBC 6.8 HGB 133 PLT 98 NA 134 K 3.9 CREA 124 SUGGEST CORO ANGIO ONCE
624749 S/P CVA X2 W/ NO RESIDUALS FCIII PT 11.6/1.02/95.5% PNEUMONIA IS CLEARED
7/2017 ECHO: EF 67% N LVD W/ NC AND SF, MILD AR, MR, MILD PULMO TAMSULOSIN CLOPI ATOR
IREA\SARTAN BISOPROLOL OMEP
HTN
NIFEDIPINE FURO NAC USN
12/9 ECHO: EF 43% N LVD AND N WTW/ HK ENTIRE IVS AND INF LVFW FR
PIPTAZO/CIPRO
B-A, AND ANT LVFW FR B-M, DIL LA RA, MILD MR, AR, MILD PULMO HTN
(50MMHG)
3810 ADC CHAVEZ, MARIA ARF 2 CAP-MR HASCVD, VHD MOD CALCIFIC 12/8 na 127 k4.3 CREA 96 HGB 101 WBC 9.2 PLT 149
624725 GUADALUPE 90F W/ ASPIRATION AS STAGE B, LONG STANDING PTPA 12./1.13/78.5%
ALZHEIMERS DSE AF, CHA2DS2VASC 6 MRI 11/21: ACUTE INFARCT, MULTIPLE CHARTDOWN
MULTIPLE CHRONIC INFARCT HASBLED 2 MEDS: KCL TID
ACUTE LEFT CVA INFARCT NYHA FC IIIC APIXABAN-hold
ECHO JAN 2017: EF 80% INC LVMI AND RWT; NRVD WITH AWMC; DIL LA; MOD CORALAN, SOLUCORTEF, DIUMIDE
DEGENERATIVE CALCIFIC AS WITH MILD AR 1+ THE AVA IS 1.1CM2 BY CE, WITH A K,PIRACETAM, VIT B COMPLEX, NAC
PG OF 33MMHG AND MG 22MMHG THE AV LEAFLETS ARE THICKENED AND MEMANTINE, CARVED BID
CALCIFIED W/ A RESTRICTED RCC. THERE IS AAC; MITRAL SCLEROSIS W/ MILD MR;
N T AND PV WITH PR; NO PE; N PAP

11/18: CT SCAN: NO ACUTE ICH, MULTIFOCAL MALACIC FOCI

ECG AF SVR
3706 ADC CORZAON TENORIO 83F T/C CHOLANGIOCA HCVD CEA:160 CREA 1/12
624388 PLEURAL EFFUSION PROB WA CT SCAN: HEPATIC, SPLENIC METS, PROB PRINARY CHOLANGIO CA AMLO MEMANTINE ATOR TELMI
METS VS CAP 12/8 WBC 17.7 HGB 123 PLT 318 NA 130 K 3.5 CREA 98 SUPLENEX NYSTATIN OMEP
CITICOLIN EMOSEGOR NAC
T2DM NA 130 K 3.5 CREA 98
12/8 CLINDA MEROP
DEMENTIA WBC 20.1 HGB 122 PLT 350
AKI

3710 LTAN UY, ROSEMARIE 63/F MYELODYSPLASTIC SYND 12/12 HGB 106 WBC 10.7 PLT 612 JAK 2 AND U/A 12/12
624186 ANEMIA PROB SEC TO 12/11 URINE CS ECOLI REFER BACK TO HEMA
CHRONIC DISEASE UA PC > 100 12/7 HGB 95 WBC 12 PLT 531 CREA 49 K 3.5 FOLICARD
CKD SEC TO DMKD WBC 13.9 HGB 106 PLT 584 REHAB
COMPLICATED UTI UA PUS OVER 100 MEDS: KETOANALOGUE,
FRACTURE L HIP S/P IMMUNOPLUS, OSTEOGAUERD,
REPALCEMENT 2016 FIASCLEDINE, CALVIT, LANTUS,
WEPOX
PIPTAZO> 12/10 MEROPENEM
3602 MOG NG BUN BI 89F GOUTY ARTHRITIS HCVD PROB CAD SR NYHA FC IIIC 12/6 WBC 5.2 SEG 79 HGB 111 PLT 141 NA 131 K 3.7 CREA 54 12/12 AZITH LEVOCETIRIZINE
CAPMR CXR: PNEUMONIA BOTH LOWER LUNDS DIAMICRON
624593 DMT2 HOOLD COLCHICINE12/10
DEMENTIA PIPTAZO NAC
MELOXICAM COLCHICINE
ERCEFLORA ASA LEVOTHYROXIN
CLONIDINE ISMN COLOSTRUM
TELMISARTAN DILTIAZEM CITICOLINE
MEMANTINE TIDOMET
3608 TDY CHARITY ONG 83/ F CPC PEG REPLACEMENT HCVD PROB CAD PAROXYSNAL 12/11 HGB 149 WBC6 PKT 183 FEEDING 100 CC Q4
T2DM AF> SR FC II ECG SR, 1 D AVB, NSSTWC
624916 CKD AORTIC DISSECTION S/P REPAIR ECHO: 72% N LVD W/ NC AND SF, DIL LA AND RA, MILD PULMO HTN CONCORE LOSARTAN AMLODIPJNE
IDCA S/P MR, R>10YRS AGO 2013 GASMOTIN NEXIUM CORDARONE
S/P CHEMO S/P RADIO DOLCET PLAVIX(ON HOLD X 6 DAYS)
S/P PEG INSERTION 2013 KETOBEST CALTRATE PLUS APIDRA
S/P PEG REPLACEMENT 2016
S/P PEG REPLACEMENT AND
EGD 12/12

2
3609 DBY ALEX ONG 87/M CAPMR ASCVD PROB CAD LONG 12/12 INC FLUID LEFT, ACCENTUATED VASCULAR MARKINGS REFER TO PULMO
PROBABLR CVA INFARCT RIGHT STANDING AF CHA2DS2VASC 3 EF 45% DILATED LVD WITH THINNED OUT AKINETIC DISTAL HALF OF IVS, AWAITING CHEST CT SCAN
624475 CAPSULOGANGLIONIC REGION HASBLED 1 NYHA FC I MODERATELY HYPOKINETIC ANTERIOR LVFW FROM BASE TO APEX AND AWAITING CBC NA K TPAG BLOOD CS
S/P CVA INFARCT 1976
MID ANTEROLATERAL LVFW, MILDLY HYPOKINETIC BASAL ANTERIOR AND
REHAB
ANTEROLATERAL WALL CONSISTENT WITH CAD WITH SYSTOLIC
DYSFUNCTION NORMAL RVD WITH SYSTOLIC DYSFUNCTION DILATED LA MEDS: ASA, CITICOLINE, DILZEM,
AND RA MITRAL SCLEROSIS WITH MILD TO MODERATE MR AORTIC VASTAREL, LLANOL, FENOFIBRATE,
SCLEROSIS WITH AI 1+ MODERATE TR ATHEROSCLEROTIC AORTIC ROOT CAUMADIN-HOLD
MODERATE PULMONARY HYPERTENSION WITH PR APIXABAN
CT SCAN: PROBALBLE CVA INFARCT RIGHT CAPSULOGANGLIONIC REGION. CJRONIC 12/6 CEFEPIME AZITH
INFARCT RIGHT THALAMUS, LEFT CAUDATE LOBE AND RIGHT OCCIPITAL LOBE. NAC
CHRONIC SMALL VESSEL ISCHEMIC CHANGES PERIVENTRICULAR WHITE MATTER.
CEREBROCEREBELLAR BRAIN ATROPHY. ATHEROSCLEROTIC VERTEBRO BASILAR
AND INTERNAL CAROTID ARTERY. LEFT MAXILLARY SINUS DISEASE

WBC 5.8 HGB 140 PLT 145 SEG 72

VNA 136 K 3.5 CREA 114 SGPT 14 TP 66 ALB 31 GLOB 35 A/G 0.89

PT 18.2 INR 1.61 ACT 43.9%

ECG: AF SVR

CXR: CONSIDER PNEUMONIC PROCESS, L LUNG. PNEUMONITIS VS CHRONIC

INTERSTITIAL DSE. R LOWER LOBE
ASCVD, DEXTROSCLOLIOSIS, OSTEOPOROSIS
3511 CLU CALIXTO LAUREANO ARF 2 TO HCAP HCVD 12/8 WBC 7.5 HGB 96 PLT 213 PROCAL 0.21 AWAITING CHEST UTZ
621333 90/ M S/P FEM CATH INSERTION SUBACUTE TO CHROIC DVT 12/7 TRACHE GSCS PSEUDOMONAS AERUGINOSA FOR FLEXIBLE LARYNGOSCOPY AND
RIGHT 11/21/17>12/9 LEFT DISTAL FEMORAL VEINS 12/7 HGB 97 WBC 8.3 PLT 238 CREA 101 K 3.7 CHANGE OF TRACHE 12/12 8:30AM
12/5 BLD CS NO GROWTH UNDER CM
REMOVED
BUN 9.7 CREA 106 K 3.7 NA 138
TP 73 ALB 34 GLOB 0.87 NUTREN DM 150 Q4
ACUTE PERITONITIS CXR: HAZY LEFT LL THE REST ARE UNCHANGED 1LPM TM
T/C PARTIAL INTESTINAL 12/4 NA 146 K 4.3 CREA 107
OBSTRUCTION 12/3 NA 148 K 3.8 CREA 118 ALBUMIN INFUSION PLUS LASIX
CAPMR 12/2 CREA 124 NA 146 K 3.8
LARYNNGEAL CA STAGE IV 12/1: HGB 107 WBC 10.11 S77 L10 PC 249 S/P BT 1 U PRBC
S/P TRACHEOSTOMY JUNE 7, ALB 40 NA 147 K3.7 11/30: NA 151 K 4 CREA 118
2017 11/29: CREA 116, NA 151, K 3.3 11/8 MEROPENEM> TAZO
S/P PEG INSERTION 6/7/17 11/28: TP 69 ALB 35 GLOB 35 WBC 9.4 HGB 105 SEG 78 PC 269 11/23>LEVOX TAB 12/8
BLOOD CS: PSEUDOMONAS SENSITIVE TO MEROP FLUCO COMPLETED
NAC
S/P HERNIORAPHY & 11/23: CXR: PROGRESSION OF LEFT UPPER INFILTRATES WITH REGRESSION RIGHT ATO
CHANGE OF GASTROSTOMY LF RVASTATIN PREVACID
TUBE 11/7/17 11/22: HGB 93 WBC 11.6 SEG 83 PC 268 CREA 111 NA 147 K 3.0
OFFICIAL DVT: SUBACUTE TO CHRONIC DVT PARTIALLY OCCLUDING R DISTAL FEM
NEGATIVE FOR ACUTE DVT LEFT

SFA DILATED COLONIC SEGMENTS W/ REGRESSION

CXR HAZY INFILTRATES BLL, ELEVATED BOTH DIAPHRAGM
WBC 5.4 HGB 120 PC 268
NA 144 K4.2 CREA 193
PRO BNP 872
3510 MOG PAN SIY 104/ M CAPMR 12/10: ECG SR BENEPROTEIN TO OF
624640 COMPLICATED UTI 12/8 CREA 89 K 4.2 AMIKACIN 12/7
12/7 HGB 135 WBC 6.4 PLT 119 NA 141 K 4.3 CREA 91 NAC KETOBEST
HGB 124 WBC 3.9 PC 125
CREA 0.92 NA 141.9 K3.94
UA BACT 20
12/10: CREA 118 NA 131
12/9 EF 45% DILATED LVD W/ N WT WITH HYPOKINESIA OF THE ENTIRE
IVS, INFERIOR AND INFEROLATERAL LVFWS FROM BASE TO APEX
N RVD WITH NC DIL LA AN RA DIL AORTIC ROOT
N MPA THICKENED MVLS WITHOUT ROM WITH MILD MR;MAC
THICKENED AORTIC CUSPS WITHOUT ROM WITH MILD AR;AAC
N TV AND PV WITH MILD TR VERY MINIMAL PE
MILD PULMONARY HYPERTENSION (45MMHG)

CWPS DONE 10/30/17

IMPROVEMENT ONE CONTRACTILITY OF THE DISTAL HALF OF ANTERIOR
LVFW
INCREASED IN EF FROM 43 TO 45%

12/8 WBC 11.7 HGB 105 PLT 245 SEG 77

NA 131 K 4.1 CREA 125 MGH
12/7 HGB 94 WBC 11.7 PLT 200 CARDIAC REHAB
12/5 ECG: SR, LAD, NSSTWC
12/5 WBC 10.8 HGB 109 PLT 159 SEG 73 TRAMADOL, RANITIDINE ASA
HCVD 3V CAD SR>
NA 133 K 4.5 CREA 120 ATOR TRIME
PAROXYSMAL AF RVR>SR
3508 T2DM 12/2 WBC- 15.6 FROM 16.7 RBC- 3.61 HGB- 110 FROM 98 HCT- 0.323 CEFTA>TAZO 12/1> 12/11
HFREF NYHA FC II
632651 WTDG HAU TEH GO 88/M PTB ONGOING TREATMENT PLATELET- 104 FROM 100 SEGS- 80 LYMPHO- 07 MONO- 10 EOSINO- 03 CEFIXIME
S/P CA 10/30/17
S/P REMOVAL CTT 12/3 CREA- 114 FROM 122 IONIZED CA- 1.11 () MG- 0.72 (K- 3.6) PROTHROMBIN
S/P CABG 3V LIMA –LAD,
TIME- 15.7 NORMAL CONTROL- 12.9 INR- 1.24 FROM 1.15 ACTIVITY- 68.8 CARDIAC REHAB
SVG-RCA, SVG-OM4 11/29
FROM 73% APTT- 27.3 NORMAL CONTROL- 30.3 AMIO DRIP> AMIO TAB OD
11/30: K 4.0 WBC 17.2 HGB 98 HCT 283 SEG 86 PC 119 NA 138 CREA 122 CARVEDILOL
11/28 K 4 MG 0.89 CLOPID
11/26 WBC 8.5 HGB 133 PLT 209 SEG 67 BT 2MIS CT 5 MINS 15 SECS CILOSTAZOL
NA 133 K 3.4 TP 78 ALBU 44 SGPT 22 CREA 119 ICA 1.20 MG 0.80
U/A NORMAL
PH 7.45 PCO2 36.2 PO2 91.9 HCO3 24.9
CXR: FIBROCALCIFIC KOCHS RUL; CILC B LL. AA. INTACT DIAPHRAGM
2DE TPEW EF 43% DILATED LVD W/ NWT W/ HYPOKINESIA OF THE ENTIRE
IVS, INFERIOR AND AND INFEROLATERAL LVFW FR BASE TO APEX AND
DISTAL HALF OF ANTERIOR LVFW W/ DERA N RVD W/ DILATED LA AND RA
W/ LAVI OF 22.72ML/M2 N MPA DILATED ARDS W/ CALCIFIED ANT AND
POST AORTIC WALLS THICKENED MVLS W/O ROM W/ MILD MR, MAC
THICKENED AORTIC CUSPS AND CALCIFIED RCC W/O ROM W/ MILD AR,
AAC ST N TV AND PV W/ MILD TR NO THROMBUS NOR PE NOTED N PAP
W/ ESPAP OF 27MMHG BY PEAK TR JET
DVT NEGATIVE
CAROTID: <50% STENOSIS OF B ICA WITH TYPE V PLAQUE MORPHOLOGY; <
50% STENOSIS OF CCA
3504 WTDG LUI, FELOMINA 80F CAPMR HCVD DCMP NONOBSTRUCTING 12/11 HGB 139 WBC 9.3 HGB158 NA 136 K 2.9 CREA 111 FURO>DIUMIDE K
624785 HYPOTHYROIDISM SEC TO POST CAD LONG STANDING AF MVR WBC 13.4 HGB 138 HCT 0.428 PLT 184 SEGMENTERS 84 HOLD METHYLCPBAL, CLANZA
RAI NYHA FC IIIC S/P CA 2013 ASA LEVEMIR EUTHYRAX
DMT2 LEAD , BOTH LE NA 136 K 5.3 SGPT 182 CKMB 35.9(NV 9-27.3) CREA 119 ICA 1.17 METHYCOBAL IMDUR VASTRAEL
S/P STENTING LEFT DISTAL SFMA MG 0.74 PRO BNP 6209 BETALOC LIFEZAR DAFLON DILZEN
2015 TROP T HS 0.05(LESS THAN 0.02NG/ML) ISDN FURO GALVUS GLICLAZIDE
PIPTAZO 12/9
PTPA 22.8 VS 11.2 INR 2.01 32.04% APTT 22.6 VS 37.4

ARTERIAL DUPLEX: LEAD, ATHEROSCLEROTIC WITH DIFFUSELY THICKENED AND

CALCIFIED WALLS
RLE:NEAR TOTAL OCCLUSION MID TO DISTAL PTA>50% STENOSIS OF THE PROX PTA
AND PROX TO MID ATATHE REST ARE <50% STENOSIS
LLE: NEAR TOTAL OCCLUSION OF THE DISTAL PTA AND PROX TO DISTAL PERONEAL
>50% STENOSIS OF THE DPA THE REST ARE <50% STENOSIS

ELEVATED PRESSURE SECONDARY TO INCOMPRESSIBLE ARTERIES AT THE

BILATERAL DPA. BORDERLINE OCCLUSION RIGHT PTA. NORMAL ABI OF LEFT PTA

3
 CAROTID:<50% STENOSIS BILATERAL ICA, BILAT CCA AND ECA HIGH FLOW
RESISTANCE AT THE RIGHY VERTEBRAL ARTERY SUGGESTIVE OF A MORE DISTAL
STENOSISNORMAL ANTEGRADE FLOW LEFT VA
VENOUS:NEGATIVE FOR ACUTE DVTPOSITIVE FOR SVT, PARTIALLY OCCLUDING THE
BILAT SSV
THALLIUM SCAN: T/C HIBERNATING MYOCARDIUM ON APEX, APICAL, SEPTAL,
MIDVENTRICULAR ANTEROSEPTAL AND INFEROSEPTAL SEGMENTS, SCARRED
MYOCARDIUM ON INFERLATERAL MIDVENTRICLAR TO BASAL SEGMENTS, GLOBAL
HK W/ DEPRESSED LVEF 37%

12/8 ECHO: EF 48% DILATED LVD WITH HYPOKINESIA OF THE INFERIOR IVS,
INFERIOR AND INFEROLATERAL LVFW FR BASE TO APEX N RVD WITH NC
DILATED LA AND RA THICKENED MVLS WITHOUT ROM; MAC; CALCIFIED
POSTEROMEDIAL PAPILLARY MUSCLE WITH MILD MR
THICKENED AORTIC CUSPS WITH DISCRETE CALCIFICATION ALONG ITS MARGINS
WITH ROM OF THE RCC WITH INSIGNIFICANT GRADIENT ACROSS THE VALVE (AVA
OF 1.65CM2 BY CE) N TV AND LV WITH MILD TR AND MILD PR
NO THROMBUS AND NO PE NOTED MILD PULMONARY HYPERTENSION (48MMHG)
HL
REFER BACK TO GI INSERTION OF
12/9 SPUTUM CS: 12/10; HGB 105 WBC 12.2 PC 189 NA 134 K4 CREA 98
ACITENOBACTER BAUMANI
NGT
12/7 FA: YEAST ++ REFUSED CT SCAN
CAPMR
12/7 HGB 117 WBC 15.5 PLT 213 NA 151 K 3.8 MGH URO STAND POINT
BLADDER TUMOR HCVD NON OBS CAD
12/6 HGB 117 WBC 14.5 PLT 227 CREA 152 NA 153 K 2.9 HOLD TIMIFLO
3501 BPH S/P CA 10YRS AGO
WTDG CHUA YNG MARIANO 97M FOBT POSITIVE CYSTOCLYSIS
623824 DMT2 S/P PPI DDD SEC TO SSS? 3 YRS 12/4 HGB 125 WBC 17.2 PLT 227 ALB 30 11/30 PIPTAZO> CEFEPIME> CIPRO
S/P EVACUATION OF BLOOD AGO 11/28 KUB: BLADDER TUMOR TC X 7D
CLOTS 11/28 WBC 14 HGB 134 PLT 169 NA 140 K 4.2 CREA 96 TRAMADOL,TRAJENTA DUOBLOC
12.3/1.10/83.8% \
LINAGLIPTIN METFROMIN
ECG VPACED OCC PVC
GLIBENCLAMIDE

NEW BUILDING
2602 BELTRAN JOSE CARANDANG CAPMR HCVD 3VCAD, VHD, MOD AS 12/8 WBC 11.5 HGB 107 PLT 513 SEG 72 HBOT
623989 67/M CPC- T2DM STAGE D, SR NYHA FC I S/P 12/6 WBC 15.8 HGB 104 PLT 487 SEG 90 NA 133 K 3.3 CREA 78 HIGH RISK FOR INTERVENTION
11/29 WBC 13.3 HGB 114 PLT 401 SEG 79 SUGGEST CORO ANGIO-NO
S/P CVA 6 YEARS AGO CABG 2011 AT PHC
CONSENT
PAOD BOTH LE FONTAIN K 4.0 CREA 79
SEGMENTAL PRESSURE ANALYSIS-
CLASS IIB DEFERRED
ECG: SR, OLD INFERIOR WALL INFARCT FURO 40 BID K LYTE BID
S/P DEBRIDEMENT 11/30,
ECHO 11/30 EF 28% DIL LVD W/ MULTISEGMENTAL WALL MOTION ABN.
12/8 SEVERE HK TO AKINESIA OF ANT, ANTEROLAT AND INF LV FR B-A, AND D/C NAHCO3, NAC
DISTAL IVS AND INFEROLAT WALL, IMPAIRED LV DIASTOLIC RELAXARTION, NEBIVOLOL 2.5MG OD
DIL LA RA, MILD TO MOD AS W/ AVA 1.7CM, MG OF 42 W/ MILD AR, TRIV FURO> DIUMIDE K
MR, N PAP (23) MEDS: 11/29 AMPI SULB> 12/8
CEFU/COAMOX
CT angiogram of the lower extremities 12/01/17 initial reading: ISMN SIMVASTATIN CILOSTAZOL
NAC DIGOX LANOXIN CLOPI
Extensive segmental calcified plaque seen from the distal abdominal aorta
PROG DIET FURO
down to the tibial arteries. Greater than 50% stenosis seen in the proximal
portion of the right superficial femoral artery, just after the bifurcation.
Both peroneal arteries patent. Segmental vessel opacification noted in the
anterior and post tibial arteries bilaterally. Collateral vessel formation with
the peroneal artery noted in the right. Left dorsalis pedis artery patent.
Right dorsalis pedis artery not opacified.
Impression: Extensive atherosclerosis of the lower extremities
Greater than 50% stenosis of the proximal right superficial artery
Occluded right dorsalis pedis artery
2610D LTAN JOSEFINA GONZALES GIST WBC 10.6 HGB 96 PLT 231 NA 126 K 2.9 CREA 97 FOR 1 U PRBC
624701 61F S/P EXLAP EF : 65% N VD AND WT W/AWMC W/ DERA N PAP PANTOP
ISELPIN
S/P CHEMO
2620 VTS LUZ M. ROQUE 92/F CAP-HR HCVD ADHF SEC TO VHD 12/8 CHEST CT SCAN – PNEUMONIA BOTH LUNGD, PLEURAL EFFUSION, RIGHT HF 12/12
BILAT PLEURAL EFF SEVERE CALCIFIC AS ST D 1 S/P HD 12/9
CKD HNT NS NYHA IIIC O2 2 LPM
12/5 ECG: SR CRBBB SOFT DIET
S/P CENTRAL INE INSERTION
VIA R FEM FOR HD ACCESS CXR 12/2 –MINIMAL REGRESSION CONGESTION
11/30: CREA 132 WBC 14 HGB 93 PLT 185 K 4.3 NA 135
11/28
11/28: NA 147 K 4.0 CREA 182 MEDS: 12/8 MEROP/MOXI
2D ECHO 11/28 EF 73% CLVH AWMC N RVD NC DIATRIAL DILATION LAVI 37 SEVERE ATOR
CALFIFIC AS AVA 0.63CM2 MG 73.6 PG 143 MILD TO MOD ARTHICKENED MVLS IMDUR
WITH ROM OF THE AMVL MILD MR MILD TR MOD PULMO HTN 77INCIDENTAL TAZO 11/28 AMLO
FINDING OF LEFT SIDED PLEURAL EFF CLONIDINE,
WBC 6.5 HGB 119 APC 152 TROP 0.13 MB 61.8 INR 1 124% ACT CREA 198 SGPT 47
CHEST UTS: 700CC RIGHT 500CC LEFT
CXR: BILAT PERICARDIAL EFF CARDIOMEG PNA NOT RULED OUT DR WTDG SIGNED OUT
ECG: SB 1AVB CRBBB
2618 ADC IRENE SY 58/F CAPMR 12/8 HGB 83 WBC 141. HOLD CHEMO
624496 AML 3 PLT 12 LANOXIN TRIMETAZIDINE
ECG: ST O2 AT 1 LPM
WA UTZ: SPLENOMEGALY WITH MULT MASSES MORPHINE DRIP
MEDS: OMEP, ALLOPURINOL,
HYDROXYZINE- RESUMED 12/8
WBC 140 HGB 85 PLT 11 SEG 13 PAIN MANAGEMENT
NA 136 K 3.6 CREA 55
PIPTAZO>12/12
MEROPENEM/LEVOFLOXACIN

2519 DBY GREGORIA SUMERA CAPMR HCVD, LONG STANDING AF 12/9 WBC 5.9 HGB 112 PLT 274 SEG 68 NA 131 K 4.4 CREA 88 ALB 44 AWAITING U/A
624782 87F LUQ MASS PROB NEOPLASTIC MVR, NYH FC IIIC ECG AF RVR ISOL PVC 12/9 PIPTAZO AZITH
CXR: PNEUMONIA BOTH LOWER LUNGS, FIBROTIC LEFT UPPER LNOXIN
ECHO 5/2016: EF 56% N LVD W/ NC & SF, GRADE 1 DD, DIL LAM MILD AR MR, MILD NAC NEB BETZOK SIMVAST
PULMO HTN (48MMHG) POLYNERV WARFARIN KETOSTERIL
CALTARTE FOSAVANCE VERAPAMIL
LOSARTAN
2515 LTAN WANG AI XIAN 88M HAP LATE ONSET 12/20 HGB 105 WBC 22.9 PLT 215 NQ 143 K 4 CREA 144 REFER TO ONCO
624241 URINARY BLADDER CA W/ 12/4 HGB 126 WBC 24.1 PLT 293 CREA 119 K 4.3 REHAB
COMPRESSION OF COLON WBC 23 HG 115 PLT 232 NO INDICATION FOR
S/P TURBT 7/17 CREA 83.4 LK 4.3 NA 134 COLOSTOMY
COMPLICATED UTI ECG NSR IVCD NO OBJ FOR D/C ON SX
NUTRIFLEX
PIPTAZO> 12/5 MEROPENEM >
12/11 CEFEPIME/METRO
LEVOX, FLUCO
2DED 12/11
CXR REGRESSION OF PNEUMONIA DIUMIDE K > LASIX DRIP 200MG X
CAP MR 12/9 WBC 5.7 HGB 120 PLT 224 NA 136 K 4.6 CREA 134 10CC/ HR
ADHF
2510B ANTONIO DUMLAO COPNIAE ECG: ST CRBBB
LTAN DCMP PROB ISCHEMIC SR HFREF
624838 74/M BPH ASA, CLOP, DILATAIR,
FCIII
EF: 17% CLVH W/ SEVERE GLOBAL HK TO AK OF BASAL & INFERAOLAT LVF, DIL LA, DUODART,PARACETAMOL,
DILA AR CARNICOR, KLYTE,. ISMN
LEVOFLOXACIN 12/9
2505 TDY NITA LIM 85F FECAL IMPACTION HCVD 12/10 NA 143 K3.1 CREA 86 HGB 113 WBC 11.3 PC 207 SOFT DIET
624841 S/P COLONOSCOPY W/ FECAL 2d echo 11/20 KLYTE
DECOMPRESSION EF 70% Normal LVD with normal wall motion and contractility
Normal RA, LA, RV No thrombus, no PE PANTOP BISACODYL
FENOFIBRATE NIFEDIPINE ATOR
Dobu stress ECHO
11/20 Normal dobu stress echo with no significant ST segment
abnormality or myocardial ischemia demonstrated

4
 ECG 1st degree AV block
NSR, Non-specific ST T wave changes

Wbc ( 13.34 ) Hgb ( 119 ) Plt ( 262 ) Seg ( 76% )

Na 132 K 3.88 Ica 1.28

2502 DBY SIU HA YAP 87/ F OBSTRUCTIVE JAUNDICE 12/10: WBC 22.2(7.4) HGB 77(90) SEGMENTERS 88(27) PLATELET 274(278) FOR 1 U PRBC BT
624404 PROB 2 TO PANCREATIC CA TB 138.9(320.9) IB 71.9(80.6) DB 67(240.3) ALP 696(508) CBC POST BT
(HEAD) AMMONIA 38
S/P ERCP PANCREATIC Mrcp initial showed high grade biliary obstruction at level of common
MALIGNANCY hepatic duct or proximal cbd causing marked intrahepatic biliary dilatation. S/P 1U PRBC
To consider biliary stone vs mass Acute pancreatitis is also noted showing PIPTAZO 12/10
diffuse peripancreatic fat DAT
COMBIFLEX

NA 130 K4.2 TOT PROT 60 ALB 28 GLOB 32 A/G: 0.88 BIL 320.9 (NV UPTO
20.5) IND BIL 80.6(NV UPTO 17) DIRECT 240.3(NV UP TO8.6) ALP 696 (NV PANTOPRAZOLE
38-126) AMYLASE 184( NV 30-110) DUPHALAC
CREA29 LIPASE 143 RBS6.60 PT 13.1S INR 1.02 ACT 96.3% HGB90 WBC7.4
B4 SEG27 PC277
WHOLE ABD UTZ: CHOLELITHIASES AND MILDLY THICKENED GB. NON
DILATED DUCTS. NO LIVER,PANCREATIC OR RENAL PATHO DETECTED. ECG
NSR
2403 ELT PORMOCILLE, RAQUEL CAPMR DCMP PROB NONISCHEMIC SR 12/9 HGB 99 WBC 1.8 PLT 169 AWAITING CTSCAN OF CHEST AND
624330 45F INVASIVE DUCTAL CA R 2012 NYHA FC IIIC 12/8 HGB 86 WBC 2.5 PLT 243 ALB 21 K 3.9 CREA 78 NA 137 ABDOMEN 12/11
S/P BIOPSY 7/2017 12/7 HGB 87 WBC 2.8 PLT 302 CREA 174 K 3.8 S/P BT 1U
CHEMO 2ND CYCLE 12/5 NA 135 K 3.6 CREA 172
DMT2 WBC 4.5 HGB 100 PLT 659 NA 136 K 3.5 CREA 169 FUROSEMIDE IV, ISDN IMDUR
ECG SR NSTTWC ENOXAPARIN
ECHO SEPT 2017: EF 44% DIL LV W/ GEN HK AND IMPAIRED SF. LV SEGMENTS ARE KLYTE AZITH GLICLA NAC TRAJENTA
HK EXCEPT IVS W/ IS AKINETIC FR B-A, MINIMAL PERICARDIAL EFFUSION LOSARTAN ASA ATOR
(0.9CM)W/P HEMODYNAMIC COMPROMISE, MOD PULMO HTN 12/3 PIPTAZO
2410 MCS RENIE LIM 81/M CVA INFARCT L RCA AND L MCA HCVD 12/11 BUN 22.7 CREA 245K 3.6 NA 152 NO OBJECTION FOR
624470 T2DM 12/9 NA 150 K 3.8 ALB 20 CREA 314 TRACHEOSTOMY
HYPOTHYROIDISM EEG: SEVERE DIFFUSE SLOWING ON LEFT NO ORSCHED YET
ECG: SR REFERRED TO PULMO POSS TRACHE
WBC 13.5 HGB 127 PLT 288 FIO2 30%
CT: ACUTE INFARCT L RCA AND MCA AMLO, DOMPERIDONE, MANITOL,
PARACETAMOL, CITICOLINE,
CEFTRIAXONE>>PIPTAZO
CLOPID, DIUMIDE K, METHIMAZOLE,
LOSARTAN, VIT B
2412 LTAN BENJAMIN PASCUA 73/ METASTATIC PROSTATE CA 12/9 HGB 97 WBC 7 PLTR 204 FOR BT 2U
M RENAL CA CREA 53 REFER TO ONCO
UTI HGB 71 WBC 7.92 PALLIATIVE CARE
S/P NEPHRECTOMY RIGHT 2009 UA BACT 357 CIPRO CASTOR OIL
S/P TURP 2016, 2017
2413 DBY ALBERTO CUSTODIO 84/ CAPMR ADHF 1211HGB 129 WBC 5.8 PLT 222 NA 138 K 3.9 CREA 139 PIPTAZO>12/11 CEFEPIME/AZITH
M S/P CVA W/ LEFT RESIDUAL HCVD 3V CAD PX S/P CABG 1ECG SR LVH LATERAL WALL ISCHEMIA 2D ECHO
>10 YRS AGO S/P GSW LEFT 2011 ( CGH) SR LVH FC III CXR: CM BILATERAL PULMO CONGESTION CANNOT RULE OUT SPUTUM AFB
MANDIBLE >10 YRS AGO AAA S/P REPAIR 2012 PNEUMONIA
BAIAE ABG: PH= 7.418 PCO2= 40.5 HCO3= 25.7 PO2= 74.4 BE= 1.6 FIO2= 28% MONTELUKAST AMLODIPNE
DFIO2=24.8% NIRMAL ACUD BASE BALANCE WITH INADEQUATE 5MG1/2 OD ALDACTONE 25 MG
OXYGENATION 1-0-0 EZETIMIBE 10 MGOD ASA
80MG OD ALLOPURINOL 300MG
OD LIFEZAR 50MG OD
FENOFIBRATE 200MG OD
PRAVASTATIN 20MG OD
2414 ASY MANUEL SARABIA 69/ COPDIAE HCVD PROB CAD ACUTE AF RVR> ECHO: Study done in AF in MVR NO OBJ FPOR D/C
624402 M MVR FC II EF 45% N LVD and WT with hypokinetic entire IVS from mid to apex, anterior and K NBE
inferior LVFW from base to apex N RVD with NC Dilated LA No thrombus and no PE AMINOPHYLLINE DRIP
Mild pulmonary hypertension ISMN TMZ
NA 134 K3.9 CREA 91 DOXOPHYLLINE- HOLD
TROP T<50 N CKMB 32.9 METHYLPRED SALBUTAMOL
ATROVENT CLOPIDOGREL
AMIO TAB TAPDIN
2318 MOG ANITA WONG 73/F CPC- OBSTRUCTIVE HCVD 12/8 HGB 130 WBC10.2 PLT 183 NA 133 K 3.1 CREA 68 CHARTDOWN
624497 INFORM UROPAHTY SEC TO WBC 4.24 HGB 127 PLKT 226 SEG 56 PMGH MONDAY
ONLY PELVOLITHIASIS RIGHT \NA 142 K 4.1 CREA 102 DAT
S/P PYELOLITHOTOMY NAC SUPPLENEX
RIGHT 12/6 CEFTRIAXONE 12/ 7
2317 LTAN SHUK HING CHEN 88/ CPC INTERTROCHANTERIC HCVD 12/7 WBC 7.8 HGB 119 PLT 199 NA 131 K 4.6 CREA 41
624638 F FRACTURE LEFT HIP ECHO: EF 74% N LVD W/ NWT AND WAMC W/ DERA, SLIGHTLY DIL AORTIC PACU
ROOT W/ CAPAWS, MIL DPULMO HTN BILATERAL HIP PROSTHEIS
ECG SR MONDAY 7AM UNDER CM
IRBESARTAN
OLD BUILDING
12/11: hgb 121 wbc 7.8 pc 129 crea 93 k3.8
EF 37% Dilated LVD with severe global hypokinesia except for the basal
septum, inferior and inferolateral LVFWs with grade II DD N RVD with NC
Dilated LA N RA, MPA, and ARDS Thickened MVLS without ROM with
moderate MR Thickened RCC and NCC without ROM N TV and PV with mild
VASTATIN ASA FESO4 ISMN CLOPI
1501C FEDERICO RAFAREAL HCVD PROB CAD (AUG 2017) TR and PR N thrombus and no PE Mild pulmonary hypertension (55mmHg)
HLC PANTOP CAPTOPRIL AMIO CORALAN
624693 74/ M SR CHF FC III CWPS done aug 20,2017 N RVD Increased in pap from 43 to 52 FURO
mmHgTROP I 0.02
ECG SR 1DAVB
ECG OLD ANTERIOR WALL INFARCTION
NA 137 K4.1 CREA 108
HGB 120 WBC 6.9 PC 121
1502 HLC CONCHITA FERNANDO SEPTIC SHOCK SEC TO HAP LATE ASCVD PROB CAD, VHD, SEVERE 12/8: NA 139 K4.1 CREA 86 12/5 CREA 64 ALB 27 WBC 13.3 HGB 103 PLT 220 SEG BIPAP 40% ALTERNATING W/ O2AT
79F ONSET CALACIFIC AS ST D NYHA FC IIIC 90 NA 142 K 3.2 2LPM
AKI SEC TO SEPSIS ECHO: EF 52% N LVD W/ HK ANT IVS AND ANTEROLATERAL LVFW FR M-B W/ DERA, INCREASE APIXABAN TO ½ BID
DMT2 MILD MR, SEVERE CALCIFIC AS W/ AVA 0.82CM BY CE, MG OF 21MMHG AND PG BENEPROTEIN TO DIET’
S/P CVA 2007 OF 36MMHG W/ MILD AR, MILD TR, MILD HTN 41MMHG DECREASE APIXABAN ½ OD
FRACTURE L FEMUR CLOSED ECG ANTEROLATERAL WALL ISCHEMIA ALB+LASIX OD X 2 DAYS THEN
COMPLETE DIUMIDE K

BLADDER TRAINING
DECREASE ALB + LASIX OD
NAC
CEFEPIME CLINDA> METRO 12/7
LINAGLIPTIN OMEP KELTICAN
APIXABAN LANTUS CALMOSEPTIN
METFROMIN MUCINEZ VENTOLIN
ALDACTONE CLOPI CORALAN ISMN
TMZ KLYTE
1507A ADC MARK ANTHONY ACID RELATED DISEASE ASCVD 12/8: ua pc 3-6 12/7 HGB 176 WBC 16.6 S83 PC 342 UGIE 12/12 7:30AM
624622 ALFONSPO 34/ M T/C MYOCARDITIS VS NA 133 K4.9 CREA 74 SGPT 64 SOFT DIET
NONISCHEMIC CM ECG SR CIPRO 12/7
CARVEDILOL LANOXIN
FC III WA UTZ: HEPATOMEGALY W/ FATTY INFILTRATIONEF13% ECCENTRIC
ENALAPRIL DIUMIDE K
S/P CA 11/23 N CORONARIES LVH( LVMI 151G/M2 AND RWT OF 0.25) W/ SEVERE GLOBAL HYPOKINESIA
ATORVASTATIN OMEPRAZOLE
WITH ONLY THE BASAL INFEROLATERAL AND INFERIOR WALL SHOWING METOCLOPRAMIDE
SOME DEGREE OF CONTRACTILITY W/ GRADE 1 DD. DILATED RVD W/
HYPOCONTACTILE WALLS( TAPSE OF 1.53CM) DILATED LA AND RA W/ LAVI
OF 45.67ML/M2 NORMAL MPA AND ARDS THICKEND AORTIC CUSPS W/O
ROM. AAC. THICKENED AND CALCIFIED MVL W/ O ROM W/ MILD-
MODERATE MR STR. NORMAL TV AND PV W/ MILD TRAND PR NO
THROMBUS MINIMAL PE MODERATE PULMO HTN W/ SPAP OF 56MMHG

5
 BY TR JET METHOD
9/9 HOLTER: BASELINE RHYTHM WAS SINUS BRADY WITH AVE HR OF 50BPM. MIN HR OF RETRIEVE OLD CHART
R/O SEIZURE DISORDER
39BPM AND MAX OF 66BPM. THERE WERE ISOLATED PACS AND PVCS. NO VTAC NOTED. NO
SENILE DEMENTIA HCVD REFERRAL TO DR EANG IF OK W/
SIGNIFICANT ST CHANGES. THERE WAS AN INSIGNIFICANT PAUSE WITH THE DURATION OF
S/P GASTRO-COLO MILD
1.9S. NO DIARY RETURNED..
RELATIVES- NO CONSENT
1507B WTDG BASILIO DIAZ 77/ M
ESOPHAGITIS, HIATAL HERNIA, S/P AAA (INFRARENAL) REPAIR JUN AWAITING 24HR HM
ECG SR
COLONIC DIVERTICULOSIS, 2016 DIAZEPAM KEPPRA SERIQIEL
HGB 104 WBC 7 PC 114 NA 130 K4.2 CREA 318 ICA 1.23 MG 0.65
ASCENDING 8/2017 RIVOTRIL
1511 WTDG WILSON LAO 71M CELLULITIS LEFT FOOT HCVD 12/10”: HGB 108 WBC 9.7 PC 423 NA 134 K3.9 CREA 65 PMGH MONDAY
623515 T2DM 12/2 WBC 12.4 HGB 110 PLTB 439 SEG 76 K 3.5 CBC CREA NA K 11/10
S/P CVA R W/ LEFT SIDED 11/28 HGB 111 WBC 14.5 S 84 PC 277
RESIDUAL K3.2 CREA 63 INR 1.22 ACT 70.36% CLINDAMYCIN 12/1
S/P DEBRIDEMENT 11/27 11/24 WBC 19.9 HGB 122 PLT 256 NA 142 K 3.7 CREA 76 MEDS:ROSUVASTATIN
EF 65% Normal Lv dimensions and wall thickness w/ adequate wall motion MEROPENEM 11/25
and contractility w/ DERA Normal RV dimensions w/ normal contractility AMLODIPINE CILOSTAZOL
Dilated LA w/ LAVI of 30.38ml/m2 Normal RA,ARDs and MPA Thickend TRAMADOL PANTOP ROSU
VESSEL DUE F
aortic cusps w/o ROM. AAC Thickened MVL w/o ROM with mild MR. MAC
St Normal Tv and PV w/mild TR No thrombus and no PE Normal spap of
19mmHg by tr jet
1512 ADC REYNALDO ESPINO 75/ CHOLELITHIASIS HCVD ECG SR WA UTZ
624893 M T2DM PT 13.4 INR 1.19 ACT 71.3% RETRIEVE 2DED DONE AS OP
NA 131 K3.4 CREA 102 LOSARTAN AMLO
HGB 135 WBC 22.9 PC 176 CIPRO
METRO
1516 LTAN TIAN, CHIONG 75/ M CAPMR HCVD 12/10: HGB 93 WBC 9.3 PC 96 NA 156 K3.1 CREA 63
624397 T2DM ECG SR RBBB TRACHEAL CS
S/P PEG (2016) HGB 115 WBC 6.2 PC 111 AC MODE FIOS 45%
S/P TRACH 2016, 2017 NA 160 K4.5 CREA 58 LEVETIRACETAM
PT 11.8 INR 1.04 ACT 92% AMIKACIN 12/4
COMBIVENT
DOPAMINE SC X 15CC/ HR

1519 WTDG JOVITA CABRERA CAP-MR HCVD, 3V CAD DCMP 12/10 HGB 104 WBC 11 PC 375 NA 138 K4 CREA 72
623010 52/F COMPLICATED UTI (ISCHEMIC) NYHA FC III, LV 12/8 UTZ OF HEMITHORAX INITIAL: RIGHT 800CC; LEFT 500CC
T2DM THOMBUS 12/3 HGB 105 WBC 10.7 PLT 455 REPEAT CHEST UTZ 12/11
HGB ELECTROPHERESISWITHIN NORMAL MENTZER INDEX 12.17 TIBC 18.5 POSSIBLE THORA LEFT
S/P CVA 2014 WITH LEFT S/P CA 11/7
FERRITIN 18.5 S/P BT
SIDED RESIDUAL
11/27: FERRITIN 352.85 HGB123 WBC 14.3 SEG 86 PC 460 SGPT 16 SGOT 24 MG 1LPM
S/P COLO 7AM 11/24-COLONIC
0.87 AWAITING PLEURAL FLUID ANALYSIS
POLYP
T/C THALASSEMIA
11/26: MG 0.76 11/18 ERTAPENEM> MEROP 11/25>
S/P UTZ GUIDED R 12/9
11/26 INITIAL ECHO: EF 30% DIL LVD W/ NWT W/ SEVERE GLOBAL HK TO AKINESIA CEFEFIME 11/30, LEVOX 11/30  TO
EXCEPT FOR THE BASAL INF AND INFEROLATERAL LVFW AND ANT IVS FROM BASE ORAL
TO APEX WITH GRADE 2 DD; DIL RVD WITH HYPOCONTRACTILE WALLS; DIL LA;
NPRA, MPA AND ARDS; MOD TO SEVERE MR, MILD TR, MOD PE, NO AND NOR MEDS: IVABRADINE PANTOP ATOR
VEGETATION, MILD PULMO HTN PAP 52MMHG ISMN NAC
CWPS 11/2: INC EF FROM 25 TO 305 IMPROVEMENT IN CONTRACTILITY OF ANT FOLIC ACID
IVS, HYPOCONTRACTILE RV, GRADE 2 DD, MOD PE WITH NO SIGNS OF SALINASE, ATOR
TAMPONADE, NO T AND NO VEGETATION NOW NOTED FURO 20 Q12
XANOR
SILIP ECHO: EF40% DIL LVD GLOBAL HK EXCEPT INFERIOR INFEROLAT LVFW
NO THROMBUS SEEN , NO PE

11/23 WBC 9.4 HGB 82 PLT 322 SEG 55 CREA 78 K 3.9 NA 139
UA PUS 15-20
2DED OFFICIAL: EF 25% TPEW DILATED LVD WITH SEVERE GLOBAL HK TO AKINESIA
EXCEPT FOR BASAL INFERIOR, INFEROLAT WHICH SHOWS SOME CONTRACTILITY
WITH DERA, ECHO DENSITY NOTED AT THE APICAL LV SEGMENT MEAS 2.3X1.2CM
CONSITENT WITH LV TRHOMBUS, DILATED LA, MILD MR, MILD TR. N PAP
REMARK: THE PREV NOTED ECHODENSITY ATTACHED TO THE TV IS NO LONGER
NOTED AFTER 24HRS.

11/2: DVT; (-)

ARTERIAL DUPLEX; RIGHT: TOTAL OCCLUSION OF THE DISTAL PTA AND PA, NTO OF
THE PROX TO MID PTA AND PA, THE REST ARE LESS THAN 20% STENOSIS;
LEFT: TOT OCCLUSION OF THE MID TO DISTAL PTA AND DISTA PA, NTO OF MID
PERONEAL ART

1520 ADC CARMENCITA CAPMR HCVD WBC 13.4 HGB 130 PLT 242 COVERSYL AZITH ASOMEX
624809 VILLACORTE 70F NA 123 K 3.6 CREA 64 FEBUXOSTAT
ECG SR 1ST D AVB
1522 TDY (PROC) GO SIOK HUI 88/F T2DM ACUTE DECOMPENSATED 12/10: HGB 95 WBC 6.3 PC 139 CREA99 K3.7 FOR 1 U PRBC
GASTRIC CA S/P 6 CYCLES HEART FAILURE 12/8 NA 124 K2.9 CREA 86 RESUME PLETAAL, LIPITOR
HGB 100 WBC 5.9 PC 135 URINE CS
CHEMO VHD, SEVERE AS STAGE D, FC
ECHO JULY 2017: 81% CONC LVH W/ AWMC, N RVD, SEVERE CALFIC AORTIC NOREPINEPHRINE DRIP 2CC/HR
S/P FEM CATH INSERTION, R IIIC
STENOSIS 0.77, MOD MR TR, SEVERE PULMO HTN 108 AMIO TMZ BURINEX
PAD S/P STENTING? LEFT CONSUMED LASIX DRIP
KLYTE
`12/7 IMIPENEM
1526 HLC DERRICK GAPUZ 44/M ACS, NSTE CAROTID <50% STENOSIS BIL ICA TYPE III & V ; INSIGNIFICANT STENOSIS OF BIL CHART DOWN 12/11
NLEE 3 VCAD, S/P CA 12/5 CCA TYPE III READMIT 12/12
HABANA ECG: INFEROLAT WALL ISCHEMIA AS PACKAGE
MENOR CLMB 96.2, TROP I 10.1 CREA 84 SGPT 77 MG 2.07 K 4.2 NA 131 ICA 1.10 HGB158
WBC 11.0 PC 194 SEG 69
PTPA: 11.7 INR 1.04 ACT 91% APTT 27.6 PLAN: CABG-12/13 PM ON CALL
EF 47%
N LVD WITH NORMAL WT WITH HYPOKINESIA OF THE ENTIRE IVS FROM MID TO 4-4-6-4
APEX AND INFEROLATERAL LVFW FROM BASE TO APEX AVAILABLE 1 U PRBC, 4 U FFP, 4U
N RVD WITH NC CRYO
N LA ENOXAPARINE LAST DOSE 12/11 PM
N RA, MPA AND ARDS ATOR,
THICKENED MVLS WITHOUT ROM WITH MILD MR CARVE/ LOSARTAN-HOLD
THICKENED AORTIC CUSPS W/O ROM HOLD ISOKET DRIP
N TV AND PV
NO THROMBUS AND NO PE
N PAP
1527 LTAN MARIA DALENA 75/ F ALZHEIMERS DSE HCVD CT SCAN: OL DLACUNAR INFARCT R EEG
UREMIC ENCEPHALOPATHY ECG SR MEMANTINE
624415 ESRD ON MAINTAINANCE HD 2 HGB 97 WBC 10.3 PC 87 S60 RESPERIDONE
TO DM NEPHROPATHY NA 138 K3.9 CREA 413 ATENURIX
T2DM ATORVASTATIN IRBESARTAN

4A
1402 ADC ROMMEL CORO 2ND DEGREE THERMAL BURN 12/5 BLD CS NEGATIVE NUTREN OPTIMUM
47/M (73.5% TBSA) 11/2 NA 131 K 3.3 PARACET Q4
S/P DEBRIDEMENT CENTRAL WBC 6.9 HGB 93 PLT 376 SEG 83 HYDROTHERAPY
11/29 NA 130 K 3.3 PNSS 90CC
LINE INSERTION 11/21/17
WBC 6.7 HGB 102 PLT 276 SEG 80 MEDS: KALIUM, TDL DRIP T/C
S/P RPT DEBRIDEMENT
12L ECG: SINUS TACHYCARDIA CLINDAMYCIN >CIPRO
11/24/17, 11/27
CXR: PROMINENT BRONCHOVASCULAR MARKINGS 11/21 UNASYN
S/P REPEAT DEBRIDEMENT
11/21: WBC 4.4 HGB 178 PLT 181 SEG 17 BANDS 16 NA 131 K 4.1 CREA 59 ALB 21
12/2/17
MG 0.5
S/P DEBRIDEMENT 12/8
S/P BEDSIDE DEBRIDEMENT
12/10
1403 ADC BENEDICTA APOLONIO CPC FOR ORIF HCVD ACUTE ONSET AF IN 12/8 EEG FOCAL SLOWING LEFT FRONTOTEMPORAL AREA RPT CRANIAL CT SCAN 12/11
623010 89/F ZYGOMATIC FX LEFT RVR TO MVR> SR TSH 2.7 FT3: 2.88 FT4: 16.25 K 4.6 REHAB
INFEROORBITAL OS, ZYGOMATIC REPEAT CT NSIC SIZE NOT CLEARED NEURO FOR ORIF
ARCH COMMINUTED ECH; NSR, LAA AMIO DRIP> TID PO
MINIMALLY DISPLACED; WBC 7.3 HGB 105 APC 140 CREA 91 SGPT 14 NA 142 K 4.0
SUBARACHNOID HGGE, RIGHT OF 200 Q4
TEMPORAL 2 FALL CRANIAL CT SCAN: SOFT TISSUE SWELLING LEFT TEMPORAL, ACUTE AMLODIPINE 5MG OD
SUBDURAL HGGE, MINIMAL SAH LEFT TEMPORAL, MILD COMPRESSION OF MANNITOL 75CC Q 6

6
 TEMPORAL HOIRN LEFT LATERAL VENTRICLE SUGGEST REFERRAL TO
RPT CRANIAL CT 11/28: PROGRESSION OF SUBDURAL HEMATOMA NEUROPSYCH
ECHO EF 66% DIL LV W/ AWMC
1404 WTDG MELVIN VELASCO CVA RIGHT PONTINE INFARCT HCVD PROB CAD 12/9 NA 138 K3.1 CREA 107 HGB 131 WBC 7.6 S52 PC 117 MGH
624433 CARDIAC DYSRRHYTHMIA 12/8: Baseline rhythm was sinus with minimum heart rate of 35 bpm, REHAB
VT> SR FC II max of 134 bpm and ave heart rate of 72bpm. 2. There were frequent PVCs ISMN BID
noted occuring singly, in couplets, in bigeminy’s and trigeminy’s. There HOLD TELMISSARTAN
CAROTID STENOSIS RIGHT
CARVEDILOL
were 2 episodes of VEntricular tachycardia with the longest beat of 7.
ATORVASTATIN, DIUMIDE K
There were 63 episodes of nonsustained VT. 3. There were frequent PACs
LACTULOSE
noted. ASA CITICHOLINE MICARDIS TMZ
4. There were no significant St t changes 5. There were sinus pauses of up CLOPI CILOSTAZOL
to 2.6seconds 6. No symptoms reported during the study
12/8 HGB 104 WBC 10.1 PC 266
ECG SR OCC PVC
MRI: ACUTE R PONTINE INFARCT CREA 95
HGBB 145 WBC 7.2 PC 128 NA 139 K3.8

EF 78% NORMAL LV DIMENSIONS WITH HYPOKINETIC INF IVS, INFERIOR

AND INFEROLATERAL LVFW FROM BASE TO APEX WITH DERA NORMAL
RVD DILATED LA AND RA NORMAL MPA AND AORTIC ROOT DIMENSIONS
THICKENED MV LEAFLETS WITHOUT ROM WITH MOD MR, MAC
THICKENED AV CUSPS WITHOUT ROM WITH MILD AR; AAC ST NORMAL TV
AND PV WITH MILD TR NO THROMBUS AND NO PE NOTED NORMAL PAP
CAROTID: LESS THAN 50% STENOSIS OF BILATERAL ICA WITH TYPE III
NORMAL ANTEGRADS FLOW OF VA'S ARTERIAL OF LE: TOTAL OCCLISON OF
RIGHT PROX TO MID ATA WITH RECONSTITUTION OF FLOW IN DISTAL.
NEAR TOTAL OCCLISON OF LEFT PROX TO MID ATA. LESS THAN 50%
STENOSIS OF REST OF ARTERIAL SEGMENTS. NORMAL ABI
VENOUS DUP: NEGATIVE ACUTE DVT, BOTH LE. NEGATIVE VALVE REFLUX,
BOTH LE
1406 ADC JOSE YU 72M SEPTIC SHOCK SEC TO CAPHR HCVD PROB CAD, HFREF, NYHA 12/8 WBC 18.8 JHGB 104 PLT 229 K 3.9 O2 2LPM
624086 ESRD SEC TO HTN VS DMN FC IIIC 12/7; HGB 100 WBC 11.6 PC 229 S/P HD 12/8
11/30 WBC 29.1 HGB 82 PLT 166 K 5.9 REFERRED TO PULMO
11/28 CREA 11.37 NA 131 K 6.41 WBC 19.4 HGB 92 PLT 185 HOLD ENTRESTO ON HD DAYS
11/2017: ECHO EF 43% DILLVD W/ NWT W/ HK INFERIOR IVS AND INF LVFW FR NE SC X 10CC/HR TAPER BY 1CC/ HR
MID-APEX W/ DEC SYS FXN W/ ABN LC COMPLIANCE CLOPI RANOLAZINE SITAGLIPTIN
ECG NSR ISMN OMEP TMZ ATOR MUCOSTA
HOLD ASA
11/30 PIPTAZO – CEFEPIME> 12/1P
MEROPENEM
1408 BSY CECILIA MOJICA CAPMR SPUTUM GSCS - CANDIDA MGH
12/7 HGB 98 WBC 7.9 PC 207 CEFTRI AZITH X 5 DAYS
ECG SR
NA 137 K4.2 HGB 124 WBC 16.2 PC 269
CREA 86
1410 DBY FELICIANO AYROSO CPC- JEJUNAL MASS HCVD, LONG STANDING AF K 3.8 COMBIFLEX X 36 HRS
624489 82/M S/P CVA 1978 CHA2DS2VASC 4 HASBLED 2 ECG: SR, RBBB s/p 1 U PRBC
S/P EXLAP ASEGMENTAL CHRONIC DVT LEFT FS: NEUROENDOCRINE TUMOR VS MALIGNANT CA D5NR X 10CC/ HR
FUROSEMIDE 20MG Q8 FOR
RESECTION OF JEJUNOM PROXIMAL TO DISTAL 2DED: ef 71%; N LVED W/ N SEGMENTAL AND GLOBAL SYSTOLIC FUNCTION
UO<500CC
AND SIGMOID MASS POPLETEAL VEIN WITH WITH GRADE 1DD. DIL LA. MITRAL SCLEROSIS; MILD MR, MILD TR
MEDS: ATOR AMIO, TELMISARTAN,
RECANALIZATION OF RIGHT WBC 6.7 HGB 102 PLT 326 CREA 149 NA 142 K 4.5 XARELTO (HOLD)
POSTERIOR TIBIAL AND NORMAL DOBU ECHO AND ECG 12/7 METRONIDAZOLE
PROXIMAL VEIN KEFOX

1407 ADC EMELITA PAGOSO THYROID PAPILLARY CA S/P ASCVD 2 V CAD SEVERE AS
623131 61/F TOTAL THYROIDECTOMY STAGE D2 SVT SR
1998; S/P RAI HFREF NYHA FC II-III
S/P CA 11/22
S/P FAILED PTCA OF MID LAD
S/P CABG W/ AVR W/
BIOPROSTHETIC 4VG (LIMA-
LAD, SVG-OM=RAMUS, SVG-
RPDA) 12/6
12/10: PT 17.1 S INR 1.51 ACT 48.8%
12/8 WBC 16.1 HGB 112 PLT 108 BANDS 8 MEDS: CEFTA
12/7 NA 144 K 3.8 ICA 1.21 WBC 14.3 HGB 98 PLT 132 12/5 WBC 5.1 HGB PANTOP CLOPI ELTROXIN CARVE
142 PLT 208 SEG 48 LYMPHO 35 CT 10MINS BT 2MINS NA 138 K 3.7 (K LYTE WARFARIN2.5 ODHS/COLCHI BID
STARTED) TOTAL PROTEIN 62 ALB 33 GLOB 29 A/G 1.14 SGPT 83 CREA 75 PERINDOP 5 OD
ICA 1.20 MG 0.69 (CORRECTED WITH 2G MG DRIP) FBS 114.59 PT 11.9 INR DIUMIKE K CEFTA > TAZO 12/8
1.06 ACT 88.7% APTT 33.1 PH 7.43 PCO2 47.7 PO2 79.6 HCO3 31.4 O2SAT S/P 4 U PRBC 6 U PC 6 U FFP 4 U
96.6 CRYO PC

AAI BUR 50 OU 2.5 TEE POST-OP: IMPROVEMENT IN WALL MOTION AND CONTRACTILITY OF
THE PROXIMAL HALF OF ANTERIOR AND INF LVFW AND BASAL TO APICAL
LATERAL LVFW W/ CORRESPONDING INCREASE IN EF OF 46% FR 35%
NORMALLY FUNCTIONING BIOPROSTHETIC AORTIC VALVE WITH EOA OF
1.78CM2 BY CE W/ MG OF 7’MHG W/ TRIVIAL TR. NO EVIDENCE OF
PARAVALVULAR LEAK. THICKENED MVLS W/O ROM W/ MILD MR ST .
NORMAL TV AND PV W/ MILD TR NORMAL PAP.
CXR: SUSPICIOUS DENSITIES RUL CILC RIGJTN LOWER LUNG ASCVD
11/24 CREA 68 K 3.8
11/23 CREA 90
11/20 WBC 7.1 HGB 135 PLT 174
NA 140 K 4.2 CREA 73 ICA 1.20 MG 0.21

ECG: SVT ISOLATED PVC

2DED: EF 34%, SEVERE AS AVA 0.73CM; PG 37MMHG, MG 23 MMHG;

MULTISEGMENTAL WALL MOTION ABN

NEGATIVE FOR ACUTE DVT, CONSIDER CHRONIC POST

THROMBOTIC/PHLEBITIC VEIN AND REMODELING BILATERAL ICF AND
PROX DFV, BAKERS CYST RIGHT

CAROTID: CAD W/ INSIGNIFICANT STENOSIS BILATERAL ICA

1412 LTAN KHO ENG PUE 86/M CAPMR HCVD 12/1 KUB UTZ: BIL MED RENAL DISEASE 2/ MUTIPLE CORTICAL CYATA, DECREASE IN CXR 12/13
UPJ OBSTRUCTION LEFT VOLUME OF HYDRONEPHROSIS LEFT, SMALL R KIDNEY 11/29 FECALYSIS (+) YEAST NXT HD 12/12
ESRD ON HD HGB 138 WBC 8.4 PLT 267 S/P HD 12/9
11/24 HGB 108 WBC 8.5 PLT 286
PTB
11/21 WBC 9.6 HGB 118 PLT 278 11/29 AMIK
MENINGIOMA
MEDS: FLUCONAZOLE ERCEFLORA
RENAL PELVIC MASS, LEFT EF 60% NORMAL LVD WITH AWMC WITH DERA NORMAL RVD WITH NORMAL LEVITERACRETAM
S/P COLONOSCOPY MULTIPLE CONTRACTILITY NORMAL LA AND RA NORMAL MPA AND ARDS THICKENED AORTIC ATOR SEVELAMER INH ETHAMUBTOL
RECTAL ULCER S/P CLIPPING CUSPS WITH NO ROM WITH MILD AR, AAC THICKENED MVLS WTHOUT ROM WITH PERINDOPRIL+AMLODIPINE
S/P PROCTOSIGMOIDOSCOPY MILD MR, MAC ST N TV AND PV WTH MILD TR NO THROMBUS AND NO PE NOTED 12/6 MEROPENEM
8/15 – (S/P EPI INJECTION, NORMAL PAP CWPS DONE 9/16/2016: NO SIGNIFICANT CHANGE
CLIP IN PLACED)
S/P LIGATION OF ANAL WAUTZ: Interval decrease in amount of massive pyonephrosis on left
BLEEDERS 8/16 kidney now at 138 cc (previously 279cc) following nephrostomy Bilateral
chronic medical renal disease with multiple cortical cysts Cystitis with
S/P CYSTO RPG W/ PCN LEFT minimal urinary bladder sediments Prostatomegaly with homogenous
8/29 parenchyma with concretions
S/P NEPHROSTOMY TUBE
INSERTION 11/26

1415 ELT (PROC) ROSAURO PEREZ 71M CKD SEC TO GOUTY HIE SEC TO CP ARREST (2 EPI) 12/5 HGB 153 WBC 5.8 PLT 100 NA 134 K 6.5 CREA 1112 BUN 77.7 DNR, CONT ALL PRESENT MEDS
624529 ARTHRITIS 12/7 12/6: K 6.4 REFUSED HD
CP ARREST 12/8 ( 4 EPI) ECG INFEROLAT ISCHEMIA 12/7 MEROP POST HD
NOREPI 32MG X 30 CC/HR
DOBU DC X 20 CC/HR
OMEP NAHCO3 CACO3 FURO PLASIL
NEB

7
1416 RLIM LONG CHI TY 79/ F FEMORAL NECK FRACTURE, ASCVD PROB CAD 11/29 HGB 98 WBC 10.7 PLT 236 NO OBJ TO D/C REHAB/ORTHO
RIGHT 2 TO FALL NA130 K4 W12 H121 PC259 S80 WISE
S/P BIPOLAR HIP PROSTHESIS , R CREA76 DAT
11/28 PT1.08 ACT 83.6% REHAB
EF83% BASELINE ECHO: NORMAL LV CAVITY W/ MILD BASAL SEPTAL HYPERTROPHY
W/ HK BASAL INFERIOR SEGEMNTS W/ DENSE ENDOCARDIUM. DILATED LA(LAVI MEDS: CLEXANE OD-LAST DOSE
36.82ML/M2). NORMALRA AND RV. THICK. MV W/O ROM. THICK AORTIC VALVES 11/28 CEFUROXIME
W/O ROM. NO THROMBUS. NO PE. PSEUDONORMAL E/A W/ LAT E/E OF 23.3 PARACETAMOL
INDICATIVE OF LV COMPLIANCE ABNORMALITY. PAP 39MMHG.
DSE: UNIFORM INCREASE IN CONTRACTILITY OF ALL SEGEMNTS W/NO STRESS HOLD ASA 11/25
INDUCED WMA INCLUDING THE HYPOKINETIC ASAL INFERIOR SEGMENTS.
DS ECG: NO SIGNIF. ST SEGEMNTS. FREQUENT PAC OCCURING SINGLY AND IN RUNS
AND OCCASIONAL PVC OCCURING SINGLY AND IN BIGEMINY DURING AND AFTER
DOBU INFUSION.
CONCLUSION:
NORMAL DOBU W/ VIABLE MYOCARDIUM BASAL INF SEGMENTS(RCA DISTR)
W/NO STRESS INDUCED ABNO.
NORMAL DS ECG NORMAL LV DIMENSIONS W/MILD BASAL SEPTAL HYPERTROPHY
W/ MILD SEGMENTAL WMA CONSISTENT W/ CAD. DILATED LA .NORMAL GOOD
SYSTOLIC FCN W/ GRADE II DD. MV SCLEROSIS W/MILD MR. MODERATE TR. ATHER.
AORTIC RT. MILD PULMO HTN W/ PR.
1418 ADC VILLANUEVA, ROMEO TETANUS INFECFTION, DCMP NYHA FCIII TRACHE GS NO BACTERIA REMOVAL OF TRACH TUBE 12/11
54/ M MODERATE TO SEVERE 11/7: WBC 16 (11.0) HGB 127 (1290 PC 255 (226) SEG 81 CREA 41 NA 144 K 3.3 PMGH
S/P INTUBATION 11/1 (3.3) MEDS: CARVEDILOL, LOSARTAN
11/4: WBC 11.1 HGB 129 PC 226 SEG 71 NA 145 K 3.3 CKMM 1232 CREA 47 CREA VALPROIC ACID
S/P TRACHEOSTOMY &
47 PREGABALIN/BACLOFEN
CUTDOWN 11/6
LOSARTAN, LANOXIN
CTSCAN HYPERACUTE INFARCT NOT RULED OUT 11/26 A,MIK DOXY X 14 D
ECG NSR
HGB 151 WBC 12 PC 334
EF 37% DIL LVD WITH SEVERE GLOBAL HK EXCEPT FOR THEPROX HALF OF IVS AND
BASAL INFEROLATERAL LVFW W/C ARE MILDLY HK W/ DERA MILD MR, MILD TR, N
PAP 24MMHG
1448C AGP/NLEE/ VICTOR BELEY 64/M COPD NIAE 3VCAD, S/P CABG 5VG (LIMA- 12/9 WBC 10.4 HGB 107 PLT 143 CREA 64 NA 141 K 3.7 AMLO NEBI ROSU CLOPID
ZBEN MENOR/HA S/P CTT REMOVAL 12/10/17 LAD, SVG-OM3-OM4~OM5, S/P BT 1 U PRBC 4 U PC 2 FFP
BANA SVG –RPDA) 12/8 HGB 148 SEG 47 WBC 6.3 CT 9MINS BT 1 MIN APTT 33.3 NA 140 K 3.9
HCVD CREA 79 SGPT 21 ICA 1.19 MG 0.74 ICA 1.19 FBS 5.76 TP69 ALB 39 GLOB RANI CLOPI NEBIV/IBERETE/
30 ROSU/DOLCET/SYMBICORT
KALIUM
ACCT 1’56; TBT 2’10 ECHO: EF 58% DLVD W/ SEGMENTAL WMA C/W CAD W/ ADEQ GLOBAL SF
AT REST. THE IVS AND ANT WALL CONTRACT ADEQ BASE TO MID
SEGMENTS W/ MILD HK AT THE APEX. THE INFEROLAT AND ANTEROLAT
WALL HAVE ADEQ CONTRACTILITY. IMPAIRED LV DIAS RELAXATION. DIL LA,
MITRAL SCLEROSIS WITH MILD MR, AORTIC SCLEROSIS W/ TRICIAL TR,
NPAP 35MMHG
DVT: NEGATIVE FOR VEIN THROMBOSIS ON B LE
CAROTID: CAD W/ <50% STENOSIS OF LEFT ICA W/ TYPE III PM
1447B AGP VICTORINO REYES CPC INGUINAL HERNIA HCVD LONG STANDING AF EF52% STUDY DONE IN AF IN MVR DILATED LV DIMENSION W/ NORMAL DAT
624548 81M INACARCERATED LEFT MVR NYHA FC IIC CONTRACTILITY AND SYSTOLIC FUNCTION W/ FLATTENING OF THE IVS RESUME LANOXIN
S/P INGUINAL HERNIORAPHY DURING SYSTOLE AND DIASTOLE INDICATIVE OF RV PRESSURE AND TRAMADOL
LEFT 12/10 VOLUME OVERLOAD THICKENED MVLS W/ NO ROM W/ PROLAPSE OF THE
ANTERIOR LEAFLET(A2 SCALLOP( W/ MODERATE TO SEVERE MR DILATED
RV DIMENSIONS W/ NORMAL THICKNESS AND SYSTOLIC FUNCTION
DILATED LA AND RA DIMENSIONS ATHEROSCLEROTIC AORTIC RT W/
NORMAL DIMENSIONS NORMAL MPA DIMENSION THICKENED AORTIC
VALVE W/ NO ROM W/MILD AR STRUCTURALLY NORMAL TR W/ MILD TR
STRUCTURALLY NORMAL PR W/MILD PR NO THROMBUS NO PE MILD
PULMONARY HYPERTENSION W/ PAP OF 50MMHG BY TR JET METHOD.
WBC 15.6 HGB 151 PL 131 NA 137 K 4.2 CREA 108
PT 15.2/1.3457.8%
ECG AF MVR
1445A RLIM AMLAO REBECCA 68/ CPC SARCOMA RIGHT LEG ECG SR K CREA NA NBE
624635 F S/P AKA 12/8 NORMAL STRESS ECG & STRESS ECHO DAT
BASELINE: DILATED LA MITRAL SCLEROSIS WITH MR AORTIC TRAMADOL
SCLEROSIS,MILD TR, CEFIXIME
GRADE 1 DD
INR 1.11 ACTIVITY 82.0% WBC 7.9 HGB 116 HCT 0.348 PLATELET 207
BANDS 01 SEGMENTERS 56 LYMPHO 28 MONO 09 EOSINOPHIL 06
1443B ASY JOHN HENRY ACASO CPC- DIFFUSE T CELL CONSTRICTIVE PERICARDITIS 12/10: WBC: 4.3 HGB: 91 PLATE:340NEUT: 90 S/P CHEMO 12/8
621105 19M LYMPHOMA S/P PERICARDIOCENTESIS 2 TO TOTAL PROTEIN: 51 ALBUMIN: 25 S/P BT 1 U PRBC 4 U PC
PLERAL EFFUSION PROB SEC TO MODERATE TO LARGE GLOBULIN: 26 A/G: 0.96 ANC: 3870 12/2 HGB 84 WBC 0.4 PC 31
MALIGNANCY PERICARDIAL EFFUSION COMBIFLEX X36 HRS
11/30 HGB 88 WBC 0.1 PLT 39 CA 1.12 CREA 14 MG 0.71
SACRAL ULCER 9/24/17, 4/22/17 S/P DAY 21 CHEMO 11/24
11/25: NA 130 K3.1 CBC HGB W0.1 H83 PC59 11/23 HGB 85 WBC 0.9 PLT
S/P THORACENTESIS 4/18 S/P PERICARDIOCENTESIS
400CC9/24 87 K 2.0 CREA 17 S/P L- ASPARAGINASE INFUSION
S/P THORA LEFT 670CC 9/25 11/20 HGB 98 WBC 0.8 PLT 63 FIBRINOGEN 109 NA 132 K 4.0 POSS CHEMO 11/24
S/P UTZ GUIDED THORA RIGHT 11/17 WBC 0.1 HGB 99 PLT 39 SEG 49 KCL DRIP X 9 DOSES
590 CC SEROSANGUINOUS NA 131 K 2.6 K 4 HRS POST KCL DRIP
FLUID, RESIDUAL 160CC FIBRINOGEN 146
10/27/17 11/15 HGB 94 WBC 0.5 PLT 32 ANC 350 NA 120 K 3.6
11/13 NA 121 K3.1 CREA 15 GIVEN GCSF 11/17
S/P EXCISSION OF CERVICAL LN HGB 86/ WBC 0.1 S 67 PC 31 S/P CHEMO 11/17
9/30 S/P BT
CSF: ALL LYMPHO WBC 1.11
S/P THORA R 700CC 10/3
S/P BMA AND BIOPSY 10/17 10/30 WBC 64.1 HGB 115 PLT 68 SEG 02 BLAST 82 TPN
GEN LIQ
TB 0.87 IB 0.73 DB 0.15 SGPT 13 SGOT 28 CREA 50
10/27 WBC 67.9 HGB 118 PLT 89 SEG 06 MEDS: PARACET TRAMADOL
NA 140 K 3.6 CREA 63 CA 1.12 CALMOSEPTINE
PT 14.6 INR 1.27 ACT 58.9% KLYTE CA GLUC
KALIUM DURULE, OMEP,
12/2:: INITIALECHO EF 52% NLVD WITH MILDLY HK ENTIRE IVS FROM B-A. PREDNISONE -> HYDROCORTISONE,
VIT K, ALLUPURINOL, NAHCO3,
THE REST OF THE LV SEGMENTS SHOW ADEQ CONTRACTILITY. N RVD WITH
COLCHICINE
HYPOCONTRACTILE WALLS; N RA AND LA, N MPA AND ARDS, N MVLS
WITHOUT ROM, N AO CUSPSP WITHOUT ROM, ST N TV AND PV; NO 11/27 MEROPENEM X 14D
THROMBUS NOTED; MOD PE PREDOMINANTLY IN THE POSTEROLATERAL FLUCONAZOLE 12/3
AREAS WITH FIBRIN STRANDS NOTED ATTACHED TO THE VISCERAL REVERSE ISOLATION
PERICARDIUM; NO EVIDENCE OF TAMPONADE PHYSIOLOGY; THICKENED
PERICARDIUM; CWPS DONE ON 10/13/2017: MOD PE FROM LARGE
10/13 EF52% NORMAL LVDIMENSIINS WITH MILD HYPOKINESIA OF IVS. THE
REST OF THE LV SEGMENTS CONTRACTS ADEQUATELY. THERE IS BILATERAL
EXPANSION OF TGE LVFW DURING DIASTOLE. NORMAL RV DIMENSIINS
WITG HYPOKINESIA OF RVFW FROM MID TO APEX. NORMAL RA AND LA
WITH LAVI OF 11.16 ML/M2 THICKENED MVL'S W/O ROM THICKENED TV
WITH MILD TR THICKENED AORTIC CUSPS WITHOUT ROM NO THROMBUS
NOTED THICKENED AND CALCIFIED PERICARDIUM (0.66CM). MODERATE
TO LARGE PE PREDOMINANTLY LOCATED LATERAL WALL, POSTEROLATERAL
LVFW AND SUPEROANTERIOR PORTION OF THE RA WITH FIBRINOUS
STRANDS ATTACHED TO THE VISCERAL PERICARDIUM. NO EVIDENCE OF
TAMPONADE PHYSIOLOGY. REPIRATORY VARIATIONS OF THE TRICUSPID
AND MITRAL INFOLW VELOCITIES. NORMAL PAP WITH ESPAP OF 28MMHG
BY PEAK TR JET METHOD. ABOVE FINDINGS CONSISTENT WITH EFFUSIVE
CONSTRICTIVE PHYSIOLOGY. COMPARED WITH PREVIOS STUDY THERE IS
IMORIVEMENT OF WALL MOTION AND CONTRACTILITY OF THE INFERIOR
AND INFEROLATERAL LVFW NORMAL LA AND RA DIMENSIONS.
9/29 EF59% NORMAL LVD AND WALL THICKNESS WITH AKINETIC MID INFEROLATERAL AND
BASAL TO MID INFERIOR LVFW. THERE IS RESTRICTION OF MOTION OF THE LVFW DURING
DIASTOLE. DILATED RV WITH HYPOKINETIC RVFW FROM MID-APEX WITH LIMITED DIASTOLIC
MOTION. DILATED LA AND RA. THICKENED MVL W/O ROM. MODERATE TO LARGE PLEURAL
EFFUSION WITH FIBRINOUS MATERIALS NOTED WITHIN THE PERICARDIAL SPACE.

8
 RESPIRATORY VARIATIONS OF THE TRICUSPID AND MITRAL INFLOW VELOCITIES. ABOVE
FINDINGS CONSISTENT EITH EFFUSIVE-CONSTRICTIVE PHYSIOLOGY

1452C LTAN ERLINDA GO 60/F COMPLICATED UTI
624106 OVARIAN CA
AKI ON TOP OF PROBABLE
CKD PROB SEC TO DM
NEPHROPATHY
T2DM
S/P NEPHRPOSTOMY TUBE
INSERTION R 11/20
S/P NEPHRPOSTOMY TUBE
INSERTION L 11/29
UTZ GUIDED PIGTAIL
INSERTION
S/P ASCITIC FLUID DRAINAGE
1.5 L 12/8
HCVD, DCMP PROB 12/7 CREA 198 K3.6 HGB 98 WBC 24.4 PC 296 MGH ANYTIME
ISCHEMIC FC IIIC 12/6 HGB 96 WBC 26.4 PLT 292 CREA 288 K 3.6 AFTER BT
12/3 HGB 102 WBC 18.1 PLT 225 CREA 451 K 2.5 ALBUMIN
11/26 WBC 9.1 HGB 88 PLT 274 SEG 78
S/P CHEMO W/ PACLITAXEL
CREA 609 K 3.7
11/22HGB1 11 WBC 8.5 PLT 382 PTPA 19/1.0/148.62%
11/22: CREA 516 HGB 111 EWBC 8.5 PC 382 DRAINED 4L SEROUS PARACENTESIS
11/19 WBC 8.9 HGB 93 PLT 334 SEG 77 CREA 384 VIA PIGTAIL 12/6
ECG SR, LAE NSTTWC 1.5 L 12/8
UA PUS >100
CLEARED FOR CHEMO
S/P BT 1 U PRBC
11/23/17 2DED:EF 40% DILATED LV DIMENSION AND NORMAL WALL CONSUMED VOLUVEN
11/21 CEFIXIME> 11/23
THICKNESS W/ SEVERE GLOBAL HYPOKINESIA W/ ONLY THE BASAL TO MID
PIPTAZO>11/30 MEROPENEM
SEGMENTS OF INFEROLATERAL LVFW SHOWIG SOME DEGREE OF LASIX + ALBUMIN
CONTRACTILITY (GLS -12.6%) W/ DERA NORMAL RVD W/ NORMAL LIMIT OFI TO <1.5L/DAY
CONTRACTILITY BIATRIAL DILATATION NORMAL MPA ATHEROSCLEROTIC
AORTIC RT W/ MILDLY DILATED PROX ASCENDING AORTA( 3.8CM)
THICKENED MVLS W/O ROM W/ MILD MR THICKENED RCC AND NCC W/
ROM STRUCTURALLY NORMAL TV AND PV W/ MILD TR NORM W/ SPAP OF
29MMHG BY TR JET

CVOR/CV
TELE
TELE 1 ADC EDUARDO GLEMAO T/C GASTRIC MALIGNANCY HCVD 3V CAD AFRVR
623245 55M NSVT>ST>SR
PREVIOUS ACS MI FC II
S/P CA 11/23/17
VERTEBRAL ARTERY
STENOSIS TOTALLY
OCCLUDED
S/P CABG 5V GRAFET (LIMA
TO OM(RAMUS), SVG TO
LAD(ATRETIC), SVG TO D1,
SVG TO RPDA SEQ TO RPLB
W/ LEFT VENTRICULAR
ANEURSYSM)
S/P REMOVAL CTT
12/10 MG 1.94 K 3.5
12/9 METAB ALKA W/ UNDERLYING RESP ACIDOSIS BIPAP 30% I10 E5
CXR INFIL L LL XANOR HOLD
12/8: NA 138 K 3.6 ICA 1.10 MG 0.82 S/P CTT REMOVAL 12/9
12/5 NA 136 K 4.5 TOTAL PROTEIN 60 ALB 31 GLOB 29 A/G 1.07 SGPT 11 REFERRED BACK TO ONCO
CREA 101 ICA 1.21 MG 0.72 FBS 100.90 WBC 5.1 HGB 122 PLT 152 CT
10MINS BT 1 MIN SEG 57 PT 11.6 INR 1.02 ACT 95.8 APTT 32.1 NC 27.0 GL
12/4 CT CEREBRAL AND CAROTID ANGIO: TOTAL OCCLUSION OF THE KABIVEN 36 HR
EXTRAOSSEOUS, DISTAL FORAMINAL AND INTRADURAL SEGMENTS OF THE CLOPID CITI OMEP CEFTA
LEFT VERTEBRAL ARTERY CANDEZ BID, CARVE 12.5 bid
2DED: EF 46%; ECC LVH W/ MULTI SEGMENTAL WALL MOTION FLUIMI CANDE ZYKAST
ABNORMALITY WITH MILDLY DEPRESSED GLOBAL SYSTOLIC FUNCTION; N O2 @5LPLPM
PAP DIUMIDE K 1 TAB OD
WBC 7.4 HGB 19 PC 197 S/P BT 3 U PRBC 3 U PC 4 U FFP
CLINDA 12/11
U/A PUS 0-2 RBC 1-3 YEAST (+) PH 7.43 PCO2 40 PO2 77.3 O2SAT 96% CAL MAG KLYTE
BICARB 26.3 CXR FIBROTIC DENSITIES B UPPER LOBE PNEUMONITIS VS CILC LEVOPHED DRIP TC 4 CCHR
BOTH LL

K 4.4 CREA 99 PT 12.9

INR 1.13 ACT 74.4%

CAROTID ARTERY DISEASE WITH: 1. <50% STENOSIS OF THE BILATERAL

ICAS WITH TYPES III AND IV PLAQUE MORPHOLOGY AT THE AP WALLS OF
THE BULB EXTENDING TO THE PROXIMAL ICA, RIGHT AND TYPE V PLAQUE
AT THE AP WALLS OF THE BULB, LEFT 2. <50% STENOSIS OF THE LEFT CCA
WITH TYPE III PLAQUE AT THE AP WALLS OF THE MID TO DISTAL CCA. 3.
TOTALLY OCCLUDED LEFT EXTRACRANIAL VERTEBRAL ARTERY (V0-V1
SEGMENTS) 4. PROBABLE >50% SIGNIFICANT STENOSIS RIGHT
EXTRACRANIAL VERTEBRAL ARTERY (V0 SEGMENT) VS. COMPENSATORY
FLOW.
NEGATIVE FOR DVT

TELE 3 ADDATU ISIDRO BICOS CAP MR HASCVD ANTEROSEPTAL 12/11 SODIUM 128 POTASSIUM 4.2 SGPT 45 CREATININE 165 ECC CREA 12/12
65/MALE DMT2 WALL MI KILLIP 3 28ML/MIN MAGNESIUM 0.86 TROP-I 43.87 WBC 16.0 RBC 3.85 HGB 122 DSU 10AM 12/12
HCT 0.366 PLATELET 185 SEGMENTERS 89 LYMPHOCYTES 05 MONOCYTES DOBU 9.4 UKM X 5CCHR
06
ECG 4MM ST ELEVATION V2-V5 TAZOVEX
12/10 CREA 1.6 , K 4, NA 126 , ICA 1.03 WBC 13.7 HGB 107 PLATELET 164 ASA CLOPIDOGREL CLEXANE
TROP POSITIVE – ATORVASTATIN CARVEDILOL
LACTULOSE ON
CXR DONE ACCENTUATED LUNG MARKNINGS WITH BILATERAL ISOKET DRIP -CLAMP
CONGESTIVE CHANGES AND PNEUMONIC INFILTRATES RLL > LLL WITH
NODULARITIES LUL COULD BE PART OF TB OR INFLAMMATORY PROCESS
MINIMAL FLUID R CPS VS PLEURAL THICKENING

PROVISIONAL ECHO DONE EF 20% N LVD WITH AKINETIC ANTERIOR IVS

AND ANTERIOR WALL BASE TO APEX THERE REST WITH SEVERE GLOBAL
HYPOKINESIA EXCEPT INFERIOR AND ONFEROLATERAL LVFW SHOWING
SOME DEGREE OF CONTRACTILITY N RVD W/ N CONTRACTILITY MILD MR
NO THROMBUS AND PEFFUSION
ICU
WTDG JOSE TAN CHUY CAP MR BILATERAL UTZ HTX L -0 R-20/ DVT NEGATIVE
LAY PLEURAL EFFUSION 12/10 WBC 18 HGB 121 PLT 349 SEG 81 BANDS 3
4M CKD SEC TO NA 122 K 3.9 ALB 32 BUN 9.8 CREA 190 ECC 27ML/MIN ; UA 2-
2DECHO CFD
OBSTRUCTIVE 5
SPURUMGSCS
UROPATHY 12/10 HGB 126 PLT ADEQ WBC 19.1 ; UA 20-25 RBC 90-100
BLOOD CS/URINE CS
10/16 ECHO OFFICIAL RESULT SHOWED: EF 63% NORMAL
TAZOVEX 2.25 Q6
LVD WTH AWMC WTH DERA NORMAL RVD WTH NORMAL
HCVD PNSS 80 CCHR
ICU1 CONTRACTILITY NORMAL RA AND LA WTH LAVI OF
NEPHROCAN
14.7ML/M2 NORMAL MAIN PULMO ARRERY DIMENSIONS, AND
PNSS X 40 CC/H
NORMAL ARDS THICKENED MVLS WITHOUT RESTRICTION OF
MOTION WTH MILD MR, MITRAL ANNULAR CALCIFICATION
D/C CORALAN AND
THICKENED AORTIC VALVE WITHOUT ROM WTH MILD AR,
NORVASC
WTH AORTIC ANNULAR CALCIFICATION ST NORMAL TV AND
PV WTH MILD TR NO THROMBUS AND NO PE MILD PULMO
HTN WTH SPAP OF 41MMHG COMPARED WITH PREVIOUS
ECHO DONE 10/7/2016: NO SIGNIFICANT CHANGE
ICU3 DBY SAU PAO WONG 86/F SEPSIS 2 TO CAP-MR, HCVD PROB CAD REPEAT CXR: COMPARED 12/8 SHOWED NO SIGNIFICANT CHANGE IN TERMS OF DNR, CONT MEDS
622360 COMPLICATED CYSTITIS LONGSTANDING AF IN INFILTRATES AND BLUNTING OF R CPS WA UTZ 12/11: CPED 11/11/2016 NOW
PARKINSONS RVR>MVR, NYHA III-IV SHOWS LIVER TO BE NORMAL IN SIZE & ECHO PATTERN. NO FOCAL MASS. NDD.
S/P TRACHEOSTOMY 11/22 CBD 0.27 GB IS CONTRACTED BILATERAL MEDICAL RENAL DISEASE CHRONIC S/P BT X 1 PRBC
CHADSVASC6 HASBLED2
VAP CYSTITIS MARKED PROSTATOMEGALY (77G) W/ CONCRETIONS MV AC MODE 25%
S/P ATTEMPTED THORA 12/20 MG 1.61 K 3.7 CREA 112 NOREPI 8MG AT 15CC
12/20 PUS 15-20 ; MG 1.61 K 3.7 CREA 112 OF 200CC Q 4 NNUTREN OPTIMUM
12/10 CXR: REGRESSION OF INFIL RIGHT BANANA- RESUMED
CHEST UTS: BILAT PLEURAL EFF 80CC
12/9 NA 134 K 3.2 CREA 108 MG 1.3 MGDL
12/8 INITIAL CHEST CT: PNEUMONIA BILATERAL CARDIOMEGALY C
MEROPENEM 11/11/17 LD 12/10
ATHEROMATOUS AORTA BILATERAL PLEURAL EFFUSION (NOT QUANTIFIED)
COLISTIN 11/27
PERICARDIAL EFFISION
FLUCO
PANTOPRAZOLE IV,
11/30: WBC 8.5 HGB 108 PLT 201 CREA 77 ICA 1.07 MG 0.65 K 3.5 NA 138
ENERVON C SYRUP 15CC

9
 ETA CS: PSEUDOMONAS MOD GROWTH 11/28 COMBIVENT NEB Q8
11/26: HGB 87 WBC 11.0 PC 270 SEG 88 NA 144 K 3.8 TP 59 ALB 35 GLOB 24 SGPT LANOXIN,1/2 OD
36 CREA 47 FOBT (-) ENOXAPARIN 0.4 OD
11/26 CXR: NEW PNEUMONIC INFILTRATES LEFT LUNG, RIGHT LUNG INFILTRATES METOPTOLOL, ATORVASTATIN,
UNCHANGED CITICOLINE

11/22: HGB 98 HCT 286 WBC 7.6 SEG 82 NA 141 K 3.5 CREA 53 ALB 32
PROCALCITONIN 0.15

11/19 PORTABLE SFA 11/19/17 INITIAL READING: COMPARED TO 11/11/17, THERE

IS DECREASE IN THE DEGREE OF DILATATION OF THE BOWEL LOOPS. PARTIAL LARGE
BOWEL OBSTRUCTION NOT RULED OUT MINIMAL FECAL STASIS.

11/17: EEG SHOWED BACKGROUND ACTIVITY OF LOW VOLTAGE MONOTONOUS

THETA AND THETA/ DELTA ACTIVITY C/W MODERATELY SEVERE DEGREE OF DIFFUSE
CEREBRAL INJURY NONSPECIFIC IN ETIOLOGY. NO EPILEPTIFORM ACTIVITY IS SEEN
SFA: ILEUS VS SBO
D ECHO: EF 58% ECCENTRIC LVH WITH HYPOKINESIA OF ENTIRE IVS, ANTEROLAT
WALLS AND INFERIOR WALLS. DILATED LA, MILD TR, MILD PULMO HTN PAP OF
42MMHG.
ABD CT 11/9: GAS DISTENDED SMALL AND LARGE BOWEL LOOPS ARE SEEN (ILEUS).
HEPATIC CYST, MINIMAL ASCITES, HIATAL HERNIA, BILATERAL PERINEPHRIC FAT
STRANDING, BILAT RENAL CYSTS, LEFT ADNEXAL CYST, INCIDENTAL FNDINGS OF
BILAT PNA, BILAT PE, MINIMAL PERICARDIAL EFF
11/8 ABD XRAY: INCREASE IN CALIBER AND NUMBER OF GAS DISTENDED BOWEL
LOOPS WITH BOWEL WALL THICKENING DUE TO GEMERALIZED ILEUS
ICU 5 HLC ASUNCION MORILLO COPD S/P TRACHEOSTOMY HCVD AFMVR HGB 115 (127WBC 10 (8.PLT 227 (249)SEG 63 (63)BANDS 22 (13) D DIMER (2D ECHO, DVT) BUT
89/F 2014 LONGSTANDING LYM 8 (22)NA 129 (126) CURRENTLY PATIENT
TRACH GS:G+ COCCI IN PAIRS AND CHAINS-FEW UNCOOPERATIVE,
DAY 2 CEFEPIME
NAC AMLO TRIME VESSEL DUE F
OMEP
ICU 6 BSY CHONG SHING FOOK CAP MR 12/11 CXR NO CHANGE
87/F PTB I 12/10 TROP 0.05 WBC 14.5 HGB 113 PLT 174
NA 141 K 3.2 BUN 10.9 CREA 62 HBA1C 6.2 CRP 17.7 INR 1.09 82% ; SPUTUM CS
WBC 21 HGB 124 PLT 226
CREA 186 K 5.5 NA 120 TP 72 ALB 30 GLOB 42 HGB 124 WBC 21.1 SEG 57 LEVOPRONT ANTIKOCH
PC 266 TAZO 12/8 azith 12/10
Klyte tid
RETRIEVE 2DECHO CFD: EF 74% N LVD NORMAL SF MILD PULMO HTN NGT FEEDING
41MMHG

ICU7 DBY MARIO TAN 72/ M UGIB ASCVD, PROB CAD 12/10 PROCALCITONIN 79.81 ; HGB 86 WBC 16.9 PLT 62 SEG 81 MONO 11 FOR BT 1 UPRBC
605043 BLUE TOE SYNDROME R PAROXYSMAL AF IN MVR, BLOOD CS AND TRACHEAL CS
SEIZURE D/O ; SEPTIC SHOCK CHADVASC 4 HASBLED 12/8 WBC 7.5 HGB 104 PLT 83 11/27: HGB 99 WBC 4.3 PC 85 SEG 72
PROB SEC TO HAP ESDR SEC CHRONIC DISTAL DVT, R PT 11/26: HGB 103 HCT 299 WBC 6.8 SEG 71 PC 85 (56)
TO DMN, HNNS ON CHRONIC 11/25 WBC 6.8 HGB 103 APC 85 SEG 71 250 Q6 OF (PEPTAMEN)-DRIP
HD 2008 PY 12 INR 1.05 ACT 88.5% APTT 35.1 FEEDING
COLON CA S/P RESECTION PROCAL 2.27 ICA 1.32 MG 0.82 CBG Q 4 AND RELAY
1/14 S/P COLOSTOMY S/P TRACHEAL GS: G(-) FEW G(+) FEW AC MODE 35%
PERM CATH INSERTION 1/17 MEROP 11/17 LAST DOSE 12/1
S/P TRACHEOSTOMY 4/13 11/17 EEG: MOD SEVERELY GEN SLOWING OF BACKGROUND ACTYIVITY AMIK 7TH DOSE-COMPLETED
WITH PREVIOUS HISTORY OF C/W A DIFFUSE ENCEPHALOPATHIC PROCESS, NONSPECIFIC FOR ETIOLOGY, TRICLAV 12/10
S/P GASTROSCOPY 8/2: PVC IN BIGEMS, CRBBB -> BACKGROUND ACTICVITY IS OF RELATIVELY LOWER AMP C/W LAST AUG
HIATAL HERNIA, HGEC TORSADES> VF -> NSR 2017 PRIALTA 30MG OD W/OMISSION
EROSIVE GASTRITIS, TRAJENTA 5MG OD
GASTROPARESIS TRACHE CS: KLEB PNEUMONIA (ESBL POSITIVE) LANTUS 12U OD AM
ECG AF SVR W/ PVC TRIGEMS VALPROIC ACID, KEPPRA
F/A: NOPS
NOREPI 8MG AT 10CC/HR
OFFICIAL 2D ECHO 8/22/17: EF50% CLVHW/ SEGMENTAL WMA (THINNED TAPERING
OUT AND SEVERELY HK ANT IVS FROM MID TO APEX, SEVERELY HK ANT PITRESSIN 10CC
WALL, MILDLY HK BASAL INF IVS, BASAL INF SEGMENT AND DISTAL HALF EPO 10000 2X/WEEK
OF THE ENTIRE LATERAL WALL) C/W CAD W/ SYSTOLIC DYSFXN W/ GRADE I
DD
DIL LA, AORTIC SCLEROSIS W/ AI 1+ W/ INSIG GRADIENT ACROSS THE AV;
MITRALS CLEROSIS W/ MILD MR; TR LOW MODERATE; ATHEROSCLEROTIC
AORTIC ROOT; N PAP
CWP STUDY DONE 8/10/17: NEW WMA NOTED

ICU 9 LTAN ALMA UY 64F HYPOVOLEMIC SHOCK PROB
SEC TO RUPTURED VARICES
LIVER CIRRHOSIS SEC TO
HEPC
S/P EGD 11/27 (VASCULAR
ECTASIA)
S/P TRACHEOSTOMY 12/9
HIE SEC TO CP ARREST (3 EPI) 12/10 MG 1.05 K 3.1 CREA 69 WEAN 45 MINS TM
HCVD CXR: PNA PROGRESSION RPT UA
12/1 CBC WBC 18.5 HGB 125 PLT 33 CREA 123 ICA 1.03 MG 1.94
11/29: ICA 0.91 MG 0.58 ALB 19 CREA 151 KLYTE TID X 9 DOSES
HGB 124 WBC 26.1 SEG 57 PC 29 TAZO SHTED TO
HGB 59 WBC 7.3 PLT 77 CEFEPIME>MEROP 12/9
NA 132 K 4.1 CREA 51 LEVOX DAY 8
PT 16.8/1.4/45.9%
INITIAL 2DECHO EF 70% N LVD WITH N WT WITH AWMC N RVD W/ NC N DOPA 10CC/HR>OFF
LA AND RA THICKENED MVL W/O ROM WITH MILD MR THICKENED AORTIC OF 50 CCQ6
CUSPS W/O ROM N TV AND PV WITH MILD TR NO THROMBUS AND NO PE
NOTED MILD PULMONARY HYPERTENSION (51 MMHG) S/P PLT CONC 6 UNITS
OFFICIAL EEG RESULT: S/P BT 3PRBC + 1 FWB
THIS IS MARKEDLY ABNORMAL EEG SHOWING SEVERE DIFFUSE VOLTAGE MV AC 50%
SUPPRESSION OF THE BACKGROUND ACTIVITY WITH OCCASIONAL PIPTAZ 11/29
APPEARANCE OF DIFFUSE LOW VOLTAGE THETA/DELTA ACTIVITY OF 3- D5NSS 40CC
10MV. THE SEVERE VOLTAGE SUPPRESSION MAY BE FOUND IN SEVERE ; 40 CC D5NSS
DIFFUSE ENCEPHALOPATHY WHICH MAY BE FOUND IN POST CARDIAC KEPPRA, AMLO
ARREST SITUATIONS AMONG OTHERS
PLAN: FOR MESENTERIC ANGIO
ONCE STABLE

NICU

CCU
CCU 2 HLC HENRY CHUA 68/M SEPTIC SHOCK SEC TO HASCVD PROB CAD ADHF, IIIC 12/11 HGB 140 (141) HCT 0.42 WBC 7.5 (14.2) BANDS 16 (32) SEG 63 LYMPHOS 19 TROC
CELLULITIS OSA PLT 163 (130) CREA 77 (121) K 4.3 (4.9) ALBUMIN 20 AERTERIAL VENOUS DUPLEXSCAN
T2DM ISMN BID
OBESE 12/8 CREA 121 WBC 14.2 HGB 111 PLT 130 MG 1.23 PIPTAZOD5 VANCO D2
INITIAL ECHO 12/5: TPEW; EF 64% NLVD W/ HK INFEROLAT INFERIOR? DIL LA; TH GLICLA LIPIGEN FURO CILOSTAZOL
MVLS W/O ROM W/ MILD MR; N PAP JARDIANCE ENOX-HOLD
NA 141 K 3.8 MG 0.64 D DIMER 1.4 TROP 0.02 CKMB 13.6 WBC 6.7 HGB 164 PLT
144 CREA 134 SGPT 49

CCU4 RLIM ARACELI JACKSON 66F SEPTIC SHOCK SEC TO CAP HR S/P ARREST X 12 EPIS 12/11 HGB 125 (127) HCT 0.37 (0.37) WBC 18.9 (16.9) BANDS 5 (9) SEG 85 (75) BIPAP 70%
PLEURAL EFFUSION R HCVD PROB CAD LYMPHOS 6 PLT 139 (162) NA 143 (141) K 4.1 (3.7) ALBUMIN 28 SGPT 1176 (1456)
HYPERKALEMIA ACS NSTECARDIAC ARRYTHMIA CREA 113 (155) PT 18.2 (28.3) INR 1.61 (2.48) ACT 43% (24.2) LEVOPHED 20CC/HR DOBUTAMINE
JUNCTIONAL RHYTHM 12/9 NA 141 K 2.9 CREA 155 12/8 PROCAL 24.98 (INCREASED) NA 144 (133) CREA 11CC/HR ONGOING TAPERING
207 (281) ECC 22 LDH 14191 DOAPMINE 6.5CC/HR
S/P R IJ CATH 12/7 WBC 21 HGB 123 PLT 214 , NA136 K6.6>3.2; CREA281 ICA 1.02 MG 1 CITI MEROP
MUCOLVAN PANTOP
INITIAL ECHO EF 30% (42%) SEVERE GLOBAL HYPOK TO AKI EXCEPT INFEROLAT W/

10
 MOD TO SEVERE MR

DVT SCREENING 12/11: RLE: POSITIVE FOR SUBACUTE SUPERFICIAL VEIN

THROMBOSIS, RIGHT SOLEAL CONSIDER VEIN WALL REMODELING, RIGHT
COMMON FEMORAL VEIN LLE: POSITIVE FOR SUBACUTE DVT, MID TO DISTAL
PERONEAL, LEFT POSITIVE FOR SUBACUTE DVT, LEFT GASTROCNEMIUS
12/10 CKMB 12.1 CREA 132 CLOPI
12/9 WBC 4.9 HGB 121 PLT 222 SEG 40 DILTIAZEM ON HOLD
HCVD PROB CAD SB FC II
CCU5 HLC CHUA PIAN 897/ M BPH NA 141 K 4.1 CREA 138 TROP 0.02 MB 25.6 ISMN TAMSULOSIN FINASTERIDE
ECG SB CAPTOPRIL LOSARTAN
CLONIDINE
PAV
J7 WTDG RAYMOND CVA BLEED, LEFT HCVD 11/6 CREA 118 MGH PCSO
620907 FRANCISCO 42/ M PARIETOACCIPITAL AREA 11/4 HGB 165 WBC 10.9 PLT 316 NA 136 K 4.5
T2DM 10/30 CREA 103 NA 137 K 4.3 STUGERON, GASMOTIN
DIABETIC RETINOPATHY 10/28 CT ANGIO: DECREASED AMT OF INTRACRANIAL HE IN R PARIETO OCCIPITAL AMLODIPINE CARVEDILOL INSULIN
FR 17.7 TO 16.3 CC
FBS 11.1
CTSCAN: ACUTE CVD BLEED LEFT PARIETOOCCIPITAL AREA
WBC 9 HGB 164 PC 254
NA 135 K5.1 CREA 123
SGPT24
PTPA INR 1 ACT 112.2 %
K7 JSY FELICITAS MOLINA CHOLECYSTOLITHIASIS HCVD EF 75% Normal Left Ventricular dimension with normal contractility with FOR LAP CHOLE 12/11 7AM UNDE
624729 79/F T2DM adequate wall motion and contractility with doppler evidence of relaxation CM
Normal PAP
12/8 WBC 10.4 HGB 94 PLT 424 K 4.0
PT 14.6 INR 1.30 ACT 61%
K8 ADC VICITACION T/C CALCULUS GALLBLADDER HCVD ECHO: EF 65% N LVD W/ NWT W/ AWMC W/ DERA LAP CHOLE 7AM 12/11
624722 OCHANGCO 61/F ECG: SR, 1ST DEG AV BLOCK, NSSTWC KCL ATOR AMLODIPINE ISMN

12/8 WBC 12.2 HGB 146 PLT 236 SEG 79

K 2.9 CREA 60
PT 12.3 INR 1.10 ACT 83.3%
L7 RUALES DIONISIO FRACTURE FEMORAL NECK L SEC HCVD DCMP PROB ISCHEMIC WBC 10 HGB 89 PLT 206 NA 138 K 4.7 CREA 237 LOSARTAN TMZ VIDAGLIPTIN ISMN
624771 CONSTANTINO 87M TO FALL VHD SEVERE CALCIFIC AS STAGE ECG CRBBB CARBICOR CARVEDILOL
BPH C SR NYHA FC IIIC 12/9 EF 40% Dilated LVD with WT with severe global hypokinesia except for the
DMT2 basal septum and basal inferolateral LVFW with DERA
Dilated LA Severe calcific AS with AVA of 0.75cm2 by CE with PG of 33mmHg and
MG of 22 mmHg probably underestimated due to severe LV dysfunction with mild
AR Calcified aortic cusps with ROM; AAC
Thickened MVLS without ROM with mild MR N TV and PV
No thrombus and no PE noted
Mild pulmonary hypertension
L8 RUALES JOSE DELA PENA 47M CPC URETEROLOTHIASIS WBC 21.2 HGB 161 PLT 269 NA 138 K 4.2 CREA 106
624754 ECG NSR
CYSTO RPG W/ SAER LITH 12/11
12:30PM
CLEARED
12/6 HGB 125 WBC 8.3 PLT 489
12/2
ECG: ST, LVH, NSSTWC
WBC 13.0 HGB 113 PLT 404 SEG 69 MGH
CKMB 389 TROP I 0.05
HCVD ACUTE NA 136 K 3.7 CREA 80 SGPT 81 ICA 1.16 MG 0.80
R2
DECOMPENSATED MEDS: ASA, CLOPID, ATOR,
62424 WTDG LIEZL RIVA 46/F CAPMR
HEART FAILURE SEC. EF 19% Dilated LVD with normal wall thickness with severe global CAPTOPRIL, ISMN, PANTO,
5
DCMP, SR NYHA FC II hypokinesia except for the basal inferolateral LVFW which show some LK LYTE, ENOX,
degree of contractility with grade 2DD Dilated RVD with NC Dilated LA and DIUMIDE K EPLERENONE
RA Normal MPA and ARDS Thickened MVLS without ROM with low flow CEFTRI-- CEFIXIME
configuration with mild MR Thickened aortic cusp without ROm
Structurally normal TV and PV with mild TR No thrombus and no PE noted
Mild pulmonary hypertension
R6 ELT JOVITA REGIS 81F CAPMR HCVD, DCMP PROB 12/ 7 NA 134 K6.9 CREA 169 MG 0.93 ICA 1.14 DNR DNI DO NOT DEFIB NO LABS
624021 MENINGIOMA RIGHT BASAL ISCHEMIC, LONG STANDING 12/2 WBC 9.0 HGB 103 PLT 165 SEG 76 CREA 153 NA 133 K 4.8 O2 AT 1 LPM
GANGLIA AF MVR, NYHA FC IIIC 11/30 WBC 10.2 HGB 121 PLT 180 NA 126 K 4.6 CREA 155 DECREASE FURO ½ TAB OD
R/O CVA ECG AF MVR LBBB DEC ELIQUIS TO OD
EF 33% DIL LV W/ SEVERE GLOBAL HK TO AKINESIA EXCEPET FOR PROX
HALF OF LVFW W/C SHOE SOME DEGREE OF CONTRACTILITY CA GLUCO FURO
PANTOP CEFTRI COMBIVENT
ATOR ISMN
PLAN TO OVERLAP W/ ORAL
ANTICOAG
HOLD APIXABAN -- ENOX HOLD
RESUME APIABAN

R5 ADC MA BETTY CHENG CAPMR HCVD PROB CAD, SR, HFREF ECG SR , LVH PULL OUT MV
62/ F BAIAE NYHA FC II NA 139 K4 SGPT 27 CREA 71 O2 1LPM
HGB 158 WBC 14.1 PC 534 ATORVASTATIN, CLOPID
EF 40% N LVD AND WT WITH HK ENTIRE IVS, ANTERIOR AND INFERIOR PIPTAZO 12/8/17 HYDROCORT
LVFW FR BASE TO APEX WITH DERA N RVD WITH NC N LA AND RA N MPA SALB +IPRA
AND ARDS THICKENED MVLS WITHOUT ROM THICKENED RCC AND NCC LEVOPHED 8MG X 10CC/ HR
WITHOUT ROM WITH MILD AR N TV AND PV WITH MILD TR NO TAPERING DOWN BY 1 CC/ HR
THROMBUS AND NO PE NOTED MILD PULMONARY HYPERTENSION
(39MMHG)
R7 ASY TEODORA BAIAE ACUTE PULMO CONGESTION HGB 132 WBC 14.8 PC 289 MGH
MANALANSAN 84/ F ACS STEMI ANTEROLATERAL NA 138 K3.1 CKMB 35 TROP 1.15 PIPTAZO 12/7
WALL KILLIP III CREA 103 ASA CLOPI AMIO IRBESARTAN
ECG ST ELEV V3-V6 O2 1LPM
S1 ELT CATALINA POHANES CAPMR HCVD CHEST CTSCAN: TB PMGH 12/11
624612 73F PTB WBC 12.3 HGB 95 PLT 279 ANTI TB MEDS
ECG NSR LVH NSTTWC TRANEX PIPTAZO SINECOD OMEP
MOSEGOR

CHARITY
FM FRANCISCO YOLANDA SOLEDAD CHD ASD SECUNDUM TYPE 9/2017 EF 67% N LVD W/ NC; N RVD W/ N C DILATE LA AND RA AAC REPEAT 12 L ECG 12/11
/LUGTU/AN 63/F 2.4:1 L>R SHUNT MAC ASD SECUNDUM 2:1 L>R SHUNT
ICOTONDO SVT, PROB PAROXYSMAL AF TR MODERATE DERA N PAP 45 MMHG CBC PC CREASGPT NA K ICA MG
/TAN/PALM 2ND DEG AV BLOCK VARYING CXR AP HS
EA 2:1 3:1 W/ PACS PRB DRUG
INDUCED FLECAINIDE VERAP – HOLD
SILDENAFIL 50 MG ½ BID
CLOPID 0D SIMVA 20
BERAPROST /RIVOTRIL ½
MM3 E. ANG ROLINDO SANGRE COAGULATION DISORDER RIGHT PORTAL VEIN TRIPHASIC CT SCAN – RIGHT PORTAL VEIN THROMBOSIS 2DED
/RAMOS/M 55/M MOST LIKELY ACQUIRED THROMBOSIS REFERRED TO HEMA – NO NEED
UKARAM/B LIVER CIRRHOSIS PROB SEC ECG: SB FOR ANTICOAGULATION
ELISARIO/M TO HEPA B INFECTION UTZ: SUGGESTIVE OF PORTAL VEIN THROMBOSIS
ARQUEZ S/P PARACENTESIS 12/1/17
S/P RBL 2012 WBC 6.5 HGB 121 PLT 63 SEG 71
APTT 44.3
NA 134 K 3.6 ASPT 99 AGOT 203 CREA 47 PT 16.9 INR 1.47 ACT 45.5
ER

11
ER TDY WONG CHIU KEE. 69/ INTERESTITIAL LUNG DISEASE HASCVD S/P MI S/P PTCA PROX FOR HRCT OF CHEST WITH CHEST
MALE OCT 2017 LAD AND OSTIAL TO PROXIMAL LAST JULY 2016 2DECHO EF 61% BY SIMPSON N LVD W/ N CONTRACTILITY AND PULM ANGIOGRAM ONCE CREA IS
NPCA DIAGNONAL BRANCH 2009 SYATOLIC FUNCTION N RVD AND CONTRACTILITY DILATED LA AND N RA, GR I NORMAL FOR CBC CREA NA K ,
S/P CVA NIF FC IIB DIASTOLIC DYSFUNCTION MILD MR AND TR MILD AR. N PAP LAST GENE XPERT, QUANTIFERRON,
CARDIAC ARRYHTMIA? FEB 2016 TREADMILL ECHO N TREADMILL STRESS ECHO 8.4 METS (90% MPHR) N SPUTUM GSCS AND AFB ABG ,
TREAMILL STRESS ECG AT 8.4 METS 2DECHO CFD

ECG: SR LAE LVH OLD INF WALL INFARCT ON PREDNISONE 5MG 1-1-1
DOXOFYLLINE 200 1-0-1 ZEPIM 1G
LAST CXR NOV 2017 BILATERAL PNEUMONITIS NO REPEAT REQUESTED BY PULMO IVT Q12 DUODART, CORDARONE,
CLOPIDOGREL, MUCOSTA,
NORVASC 5MG 1/2 PRN, ZOLPIDEM
PENTOXYFYLLINE
ER

12